GO	[-5.62 -0.71]	[-0.71 -0.36]	[-0.36 -0.19]	[-0.19 -0.05]	[-0.05 0.00]	[0.00 0.00]	[0.00 0.10]	[0.10 0.28]	[0.28 0.55]	[0.55 1.06]	[1.06 7.84]
PUJANA_XPRSS_INT_NETWORK PUJANA_XPRSS_INT_NETWORK	-0.813	20.004	9.013	1.507	-1.926	-6.985	-0.634	-1.578	-3.355	-5.731	-5.713
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	0.693	15.917	6.581	2.414	-3.060	-4.638	-1.608	-2.485	-1.608	-5.817	-5.801
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	0.406	6.992	9.630	6.509	-2.599	-6.693	-0.543	-1.755	-3.765	-5.456	-4.506
WINNEPENNINCKX_MELANOMA_METASTASIS_UP WINNEPENNINCKX_MELANOMA_METASTASIS_UP	-1.779	20.915	4.268	2.212	-2.628	-5.496	-0.420	-0.722	-3.165	-4.559	-3.151
PUJANA_BRCA_CENTERED_NETWORK PUJANA_BRCA_CENTERED_NETWORK	-0.613	17.011	6.807	0.735	-2.351	-4.900	-0.443	-1.432	-1.843	-4.900	-4.886
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	0.791	12.760	5.588	2.827	-1.590	-6.401	-1.960	-0.339	-4.267	-4.267	-5.166
FUJII_YBX1_TARGETS_DN FUJII_YBX1_TARGETS_DN	0.309	9.069	10.116	1.559	-4.170	-6.718	-0.506	0.309	-3.561	-2.167	-4.152
KONG_E2F3_TARGETS KONG_E2F3_TARGETS	-0.324	15.755	3.403	1.542	-4.026	-4.026	-0.324	-2.264	-1.709	-4.026	-2.255
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	-0.975	17.877	5.720	1.016	-4.194	-3.460	-1.234	-1.234	-2.341	-1.909	-1.898
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	-2.917	8.872	5.615	3.362	-0.946	-7.863	-0.263	0.567	-1.168	-3.437	-4.717
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	0.691	17.733	3.657	1.412	-3.468	-4.070	-2.094	-1.186	-1.747	-2.946	-2.081
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	1.118	13.326	4.856	0.601	-5.653	-3.936	-1.877	-0.992	-2.277	0.260	-3.920
BENPORATH_PROLIFERATION BENPORATH_PROLIFERATION	0.319	14.830	3.829	1.832	-2.728	-4.949	-1.807	-0.697	-1.153	-2.728	-3.312
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN	1.293	13.657	6.226	-0.432	-1.997	-4.630	-1.997	-1.114	-0.898	-2.831	-2.372
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	-1.192	5.475	3.539	7.290	-0.595	-6.085	-0.761	-0.959	0.462	-3.645	-6.066
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	0.985	9.449	6.369	2.474	-2.657	-4.595	-3.196	-1.182	-1.804	-1.804	-2.644
WHITEFORD_PEDIATRIC_CANCER_MARKERS WHITEFORD_PEDIATRIC_CANCER_MARKERS	0.755	11.907	5.320	1.190	-2.947	-3.752	-1.815	-2.319	-1.815	-1.408	-2.309
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	-0.388	15.132	4.757	0.610	-2.043	-3.227	-1.609	-0.963	-2.573	-3.227	-0.956
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	0.301	13.927	3.807	0.636	-2.510	-2.510	-2.510	-0.458	-1.836	-3.485	-1.828
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	0.620	13.150	5.429	0.620	-1.637	-5.409	-0.882	-2.359	-1.973	-1.637	-1.626
CROONQUIST_IL6_DEPRIVATION_DN CROONQUIST_IL6_DEPRIVATION_DN	0.301	12.858	4.990	0.816	-1.650	-2.919	-2.197	-1.227	-1.650	-2.197	-2.910
MISSIAGLIA_REGULATED_BY_METHYLATION_DN MISSIAGLIA_REGULATED_BY_METHYLATION_DN	0.500	11.277	4.961	0.849	-1.957	-5.067	-1.533	-0.677	-1.533	-3.122	-1.524
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	-1.053	11.635	4.006	1.565	-3.652	-1.966	-0.751	-1.053	-3.652	-1.448	-1.047
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	-0.464	7.115	6.633	2.078	-0.608	-4.706	-0.464	-0.992	-0.992	-2.745	-5.635
BURTON_ADIPOGENESIS_3 BURTON_ADIPOGENESIS_3	-0.771	13.306	1.665	2.709	-2.432	-4.234	-1.858	-1.051	-2.432	-0.553	-1.045
VERHAAK_AML_WITH_NPM1_MUTATED_UP VERHAAK_AML_WITH_NPM1_MUTATED_UP	-0.327	-0.714	-3.345	-0.432	-1.114	-3.939	-3.345	-0.560	-0.560	6.673	11.329
CROONQUIST_NRAS_SIGNALING_DN CROONQUIST_NRAS_SIGNALING_DN	0.342	9.818	6.892	-0.264	-1.999	-2.903	-1.999	-0.961	-1.393	-1.999	-1.992
KONDO_PROSTATE_CANCER_WITH_H3K27ME3 KONDO_PROSTATE_CANCER_WITH_H3K27ME3	0.507	-0.517	-3.592	-3.592	2.555	12.255	-1.837	-2.597	-1.260	-1.260	2.291
RUIZ_TNC_TARGETS_DN RUIZ_TNC_TARGETS_DN	3.699	9.608	2.960	-2.576	-2.576	-4.754	-0.623	-0.465	-0.623	-1.054	-2.564
FISCHER_G1_S_CELL_CYCLE FISCHER_G1_S_CELL_CYCLE	1.843	11.696	3.242	0.692	-2.342	-4.403	-1.130	-1.130	-1.654	-2.342	-1.363
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	-1.260	3.160	5.744	2.555	-2.192	-6.758	1.124	0.944	-0.517	-3.061	-3.576
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	0.276	9.919	4.971	1.162	-1.828	-4.632	-0.957	-0.328	-2.224	-1.201	-3.214
KRIGE_AMINO_ACID_DEPRIVATION KRIGE_AMINO_ACID_DEPRIVATION	18.561	-1.202	-1.202	-1.202	-0.610	-1.202	-1.202	-1.202	-1.202	0.572	-0.608
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	-3.253	1.584	3.620	3.975	-1.594	-6.322	0.514	1.825	0.799	-1.308	-5.316
KARLSSON_TGFB1_TARGETS_UP KARLSSON_TGFB1_TARGETS_UP	-0.366	3.577	10.500	0.828	-1.558	-5.108	-1.558	-1.985	0.486	-2.509	-0.917
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	-2.359	1.769	1.769	3.881	-1.637	-6.401	0.932	4.246	-0.548	-1.347	-4.577
REN_BOUND_BY_E2F REN_BOUND_BY_E2F	0.970	11.232	2.474	-0.301	-2.571	-1.152	-0.489	-1.152	-1.712	-2.571	-2.564
SCHUHMACHER_MYC_TARGETS_UP SCHUHMACHER_MYC_TARGETS_UP	0.724	11.349	1.555	0.353	-1.225	-3.319	-0.255	-0.596	-0.865	-3.319	-3.310
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	1.231	11.481	2.602	0.539	-1.477	-2.696	-1.477	-1.477	-2.696	-1.999	-1.072
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	0.884	-1.474	-4.085	-2.256	0.310	-2.759	-0.921	-0.292	-1.173	3.042	11.453
DANG_MYC_TARGETS_UP DANG_MYC_TARGETS_UP	-0.610	6.341	5.838	0.881	-1.063	-4.251	0.533	0.282	-1.369	-3.404	-3.391
RAMALHO_STEMNESS_UP RAMALHO_STEMNESS_UP	-1.278	2.813	3.782	4.882	-1.860	-8.114	-0.310	0.926	-1.045	-1.549	-1.269
UDAYAKUMAR_MED1_TARGETS_UP UDAYAKUMAR_MED1_TARGETS_UP	0.451	1.406	10.325	0.763	-2.365	-5.650	0.954	-0.703	-0.703	-1.899	-2.354
RICKMAN_HEAD_AND_NECK_CANCER_C RICKMAN_HEAD_AND_NECK_CANCER_C	2.076	-1.787	-2.288	-2.288	-0.582	12.748	0.311	-3.714	-1.055	-0.418	0.598
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	-2.256	2.456	8.242	0.795	-2.256	-4.775	0.795	0.610	-0.567	-1.034	-2.867
KAUFFMANN_DNA_REPLICATION_GENES KAUFFMANN_DNA_REPLICATION_GENES	0.329	8.658	3.881	0.923	-1.429	-4.910	-1.429	0.445	-0.886	-2.698	-1.771
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	0.416	11.781	2.015	0.245	-1.466	-2.280	-0.600	-0.949	-0.949	-2.280	-2.274
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	-0.676	-1.646	-1.646	-4.108	-1.646	-0.521	-1.646	-0.395	1.667	2.193	11.609
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	-0.302	9.506	2.850	1.765	-0.829	-3.592	-0.659	0.301	-1.528	-3.061	-3.046
ISHIDA_E2F_TARGETS ISHIDA_E2F_TARGETS	-0.316	8.834	2.690	1.364	-1.362	-2.156	-0.865	-0.535	-2.156	-2.156	-2.150
MORI_IMMATURE_B_LYMPHOCYTE_DN MORI_IMMATURE_B_LYMPHOCYTE_DN	-0.391	10.443	2.119	2.119	-2.770	-2.065	-1.127	-0.812	-2.065	-1.127	-1.527
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	-2.397	1.403	1.403	2.199	-2.914	-6.401	0.974	3.906	0.791	-1.590	-1.949
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	1.150	9.318	0.597	1.377	-2.667	-6.067	-0.503	-0.667	-0.503	-0.869	-1.398
LEE_LIVER_CANCER_SURVIVAL_DN LEE_LIVER_CANCER_SURVIVAL_DN	-0.993	5.784	3.116	2.209	-0.993	-5.186	1.045	-0.270	-0.993	-3.132	-2.191
MOOTHA_VOXPHOS MOOTHA_VOXPHOS	-1.933	-0.338	-1.420	4.080	-1.029	-3.610	4.080	2.712	0.782	-2.621	-1.926
VERNELL_RETINOBLASTOMA_PATHWAY_UP VERNELL_RETINOBLASTOMA_PATHWAY_UP	-0.422	8.301	4.412	-0.264	-0.422	-2.903	-0.647	-0.961	-0.961	-1.393	-2.895
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	-2.862	-0.626	-0.626	1.029	0.357	-2.862	8.445	2.484	-1.963	-1.363	-0.930
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	0.344	10.893	2.530	-0.354	-4.350	-2.606	-0.468	-0.976	-0.262	-1.211	-0.968
EPPERT_PROGENITOR EPPERT_PROGENITOR	1.351	4.819	3.968	0.912	-2.425	-5.734	0.310	-0.959	-0.735	-1.559	-1.550
JISON_SICKLE_CELL_DISEASE_UP JISON_SICKLE_CELL_DISEASE_UP	-1.572	-1.288	-1.901	0.815	-2.281	-5.298	-1.044	0.987	4.783	3.322	1.867
KANG_DOXORUBICIN_RESISTANCE_UP KANG_DOXORUBICIN_RESISTANCE_UP	0.435	8.479	3.053	0.435	-2.239	-2.239	-0.578	-1.431	-1.431	-0.921	-1.426
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	-2.962	0.320	1.635	6.817	-0.719	-5.692	0.438	1.144	0.438	-0.719	-2.384
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	0.251	4.779	3.023	2.284	-1.261	-4.609	-0.508	0.367	-0.703	-1.649	-3.512
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	-2.705	0.721	1.234	3.006	-3.717	-6.916	-0.437	2.421	1.660	-0.334	-0.432
KAUFFMANN_MELANOMA_RELAPSE_UP KAUFFMANN_MELANOMA_RELAPSE_UP	-0.287	9.722	2.540	-0.287	-1.122	-2.529	0.315	-1.677	-0.738	-1.677	-1.671
LE_EGR2_TARGETS_UP LE_EGR2_TARGETS_UP	-0.493	10.736	1.991	0.905	-2.705	-2.705	-0.685	-1.237	-0.930	-0.930	-0.680
XIE_ST_HSC_S1PR3_OE_UP XIE_ST_HSC_S1PR3_OE_UP	-0.335	-1.386	-3.971	-1.132	-0.728	-0.572	-3.971	0.468	1.074	4.912	5.342
HUANG_GATA2_TARGETS_UP HUANG_GATA2_TARGETS_UP	-3.426	-0.743	-0.310	-1.214	-3.426	-4.158	0.399	1.484	2.954	2.013	3.324
SONG_TARGETS_OF_IE86_CMV_PROTEIN SONG_TARGETS_OF_IE86_CMV_PROTEIN	0.910	6.045	2.473	1.232	-2.280	-2.280	-0.949	-0.600	-2.280	-0.949	-1.461
DAZARD_UV_RESPONSE_CLUSTER_G6 DAZARD_UV_RESPONSE_CLUSTER_G6	0.359	0.359	7.294	1.197	-0.478	-5.984	0.359	0.795	-0.638	-1.362	-3.179
WHITFIELD_CELL_CYCLE_G2 WHITFIELD_CELL_CYCLE_G2	-1.045	2.557	4.688	2.261	-1.301	-7.027	-0.277	0.434	-0.498	-0.829	-1.590
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	-1.355	1.164	2.813	4.602	-0.733	-4.151	0.921	0.524	-0.521	-3.107	-2.356
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	-1.807	-0.976	0.884	2.835	-0.976	-6.125	3.157	1.971	1.065	-0.468	-3.087
WELCSH_BRCA1_TARGETS_DN WELCSH_BRCA1_TARGETS_DN	-0.320	4.634	4.210	0.676	-1.296	-4.677	0.852	-0.442	-0.320	-2.034	-3.080
RHODES_UNDIFFERENTIATED_CANCER RHODES_UNDIFFERENTIATED_CANCER	1.029	8.445	1.681	-0.252	-2.862	-2.862	-0.935	-0.406	-0.626	-0.935	-1.357
YU_MYC_TARGETS_UP YU_MYC_TARGETS_UP	-1.782	7.108	1.040	3.486	-1.057	-1.782	-1.057	-0.624	-1.057	-1.057	-1.053
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	-0.332	10.380	1.319	0.455	-2.197	-2.197	-0.556	-0.893	-0.556	-0.893	-1.392
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	12.480	0.357	-0.626	-1.363	-2.862	-1.363	-0.935	-0.252	0.357	-0.406	-0.622
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	-3.284	0.293	3.928	3.239	0.389	-6.362	0.389	0.633	0.502	-0.412	-2.320
WHITFIELD_CELL_CYCLE_S WHITFIELD_CELL_CYCLE_S	-0.392	8.023	1.832	0.568	-0.904	-4.949	-1.153	0.568	-0.284	-2.728	-0.691
SMIRNOV_RESPONSE_TO_IR_6HR_UP SMIRNOV_RESPONSE_TO_IR_6HR_UP	-1.027	0.574	-1.926	-1.027	-2.331	-5.731	-0.486	0.889	3.961	2.014	2.610
KAMMINGA_EZH2_TARGETS KAMMINGA_EZH2_TARGETS	-0.318	6.633	1.129	3.082	-0.991	-0.991	-0.991	-0.991	-1.699	-1.699	-1.695
DAZARD_RESPONSE_TO_UV_SCC_DN DAZARD_RESPONSE_TO_UV_SCC_DN	-0.774	0.322	3.207	3.207	-1.034	-4.775	-1.034	3.207	-0.405	-0.567	-2.867
HELLER_SILENCED_BY_METHYLATION_DN HELLER_SILENCED_BY_METHYLATION_DN	13.305	-0.869	-1.540	-0.869	-1.167	-2.009	-0.869	-0.312	0.290	-0.451	0.581
WANG_CLIM2_TARGETS_DN WANG_CLIM2_TARGETS_DN	-3.223	0.987	4.395	2.685	-0.392	-5.298	-0.293	-0.293	0.987	-0.392	-2.704
MEBARKI_HCC_PROGENITOR_WNT_UP MEBARKI_HCC_PROGENITOR_WNT_UP	3.362	-1.078	-2.678	-1.078	0.892	-2.678	-3.686	0.367	-0.427	1.463	4.805
WHITFIELD_CELL_CYCLE_G2_M WHITFIELD_CELL_CYCLE_G2_M	0.270	5.116	3.321	1.439	-1.095	-5.053	-0.334	-0.334	-0.562	-0.889	-3.161
VILLANUEVA_LIVER_CANCER_KRT19_UP VILLANUEVA_LIVER_CANCER_KRT19_UP	-0.732	7.434	3.283	0.485	-3.580	-2.523	0.372	-0.570	0.276	-1.424	-1.146
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	-0.302	-0.829	-1.837	-1.837	-2.192	-3.592	-1.028	1.765	2.275	2.555	4.204
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	1.588	-2.250	-2.715	-2.715	0.268	0.364	-1.512	-0.594	-0.767	3.736	5.363
ODONNELL_TFRC_TARGETS_DN ODONNELL_TFRC_TARGETS_DN	0.391	8.643	1.516	1.516	-1.016	-1.296	-0.442	-3.093	-1.016	-2.034	-1.008
GOLDRATH_HOMEOSTATIC_PROLIFERATION GOLDRATH_HOMEOSTATIC_PROLIFERATION	-1.452	1.568	0.319	6.477	-0.904	-4.049	0.568	1.568	-0.697	-0.528	-3.312
WHITFIELD_CELL_CYCLE_G1_S WHITFIELD_CELL_CYCLE_G1_S	-0.656	4.691	6.110	0.255	-2.276	-3.511	0.255	-0.486	0.255	-1.125	-1.431
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	0.412	4.438	2.096	2.501	-0.775	-3.153	-0.523	-0.523	-0.775	-1.580	-3.144
PUJANA_BREAST_CANCER_LIT_INT_NETWORK PUJANA_BREAST_CANCER_LIT_INT_NETWORK	0.359	4.050	3.166	2.028	-1.828	-4.192	-0.373	-0.537	-0.537	-1.029	-2.389
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP	-0.490	-0.652	-2.145	-3.940	-0.490	-1.093	-0.360	-0.490	-0.258	8.282	2.888
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	0.814	4.742	3.492	0.546	-2.031	-2.031	-1.259	-0.472	-0.472	-1.259	-2.026
LEE_EARLY_T_LYMPHOCYTE_UP LEE_EARLY_T_LYMPHOCYTE_UP	0.542	7.650	2.373	0.721	-2.671	-1.214	-0.668	-0.668	-0.479	-2.671	-1.586
HOLLERN_SQUAMOUS_BREAST_TUMOR HOLLERN_SQUAMOUS_BREAST_TUMOR	-0.533	0.301	-3.483	-2.026	3.768	5.779	-1.100	-1.669	-1.362	0.301	1.201
KARLSSON_TGFB1_TARGETS_DN KARLSSON_TGFB1_TARGETS_DN	-0.844	-1.860	-0.672	2.244	-2.624	-6.797	0.622	1.104	1.299	2.244	0.935
ROSS_AML_WITH_MLL_FUSIONS ROSS_AML_WITH_MLL_FUSIONS	-1.225	-2.363	-0.397	0.353	-3.319	-2.363	-0.865	3.136	3.608	1.902	0.356
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	-0.552	-2.605	-2.072	-0.744	-1.277	-0.744	-1.635	0.445	0.445	5.640	5.178
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	-2.473	0.657	2.946	4.926	-1.803	-2.473	1.439	-0.289	-1.803	-0.442	-1.302
JISON_SICKLE_CELL_DISEASE_DN JISON_SICKLE_CELL_DISEASE_DN	-1.681	0.593	0.593	5.315	-1.386	-2.860	2.507	1.962	-0.572	-2.411	-2.008
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	0.597	3.102	5.698	-0.431	-0.729	-1.948	-0.729	0.370	-1.948	-1.191	-1.943
DANG_REGULATED_BY_MYC_UP DANG_REGULATED_BY_MYC_UP	0.790	1.062	5.189	2.119	-1.927	-2.820	-0.606	-0.606	-0.390	-0.910	-2.812
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	-0.291	0.593	0.439	2.771	-3.714	-3.714	0.983	2.412	1.218	-1.787	-2.278
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	-1.706	-1.706	-1.706	-2.606	-1.362	-0.350	-1.074	1.963	1.687	1.431	5.823
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	2.714	-2.051	-4.177	-1.691	0.801	1.861	-0.704	-1.691	0.292	-0.545	4.496
GAVIN_FOXP3_TARGETS_CLUSTER_P6 GAVIN_FOXP3_TARGETS_CLUSTER_P6	-0.391	9.727	1.168	0.504	-2.065	-2.770	-0.812	-0.258	-0.812	-1.127	-0.568
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	-1.099	1.998	1.998	3.865	-1.432	-2.351	0.291	1.417	-0.443	-3.790	-1.834
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	1.695	-1.321	0.318	-1.063	-1.976	0.318	-2.386	-2.386	-0.662	5.906	2.848
ZHAN_MULTIPLE_MYELOMA_PR_UP ZHAN_MULTIPLE_MYELOMA_PR_UP	-0.228	9.127	1.271	0.625	-0.702	-1.158	-1.158	-1.158	-0.702	-1.907	-1.153
PEART_HDAC_PROLIFERATION_CLUSTER_DN PEART_HDAC_PROLIFERATION_CLUSTER_DN	0.499	1.592	7.452	-0.438	-0.986	-2.945	-2.035	-0.276	0.499	-0.986	-1.418
WIELAND_UP_BY_HBV_INFECTION WIELAND_UP_BY_HBV_INFECTION	-1.460	-1.460	-0.810	-1.097	-1.097	-2.500	-1.460	1.309	0.827	4.801	3.869
ZHAN_MULTIPLE_MYELOMA_CD1_UP ZHAN_MULTIPLE_MYELOMA_CD1_UP	10.996	-0.228	-0.411	-0.702	-1.158	-1.907	-1.158	-0.228	-0.411	-1.158	0.391
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN	-1.424	0.276	1.333	0.372	-3.012	-7.278	1.333	1.559	0.938	1.126	-0.323
FARMER_BREAST_CANCER_CLUSTER_2 FARMER_BREAST_CANCER_CLUSTER_2	-0.385	7.315	2.092	0.453	-0.733	-1.367	-1.367	-0.385	-0.733	-1.367	-1.364
LENAOUR_DENDRITIC_CELL_MATURATION_DN LENAOUR_DENDRITIC_CELL_MATURATION_DN	-1.392	-2.766	-1.392	1.067	-2.218	-2.766	-0.331	0.677	1.553	1.830	4.395
TIEN_INTESTINE_PROBIOTICS_6HR_DN TIEN_INTESTINE_PROBIOTICS_6HR_DN	-2.863	1.035	1.035	1.695	-1.321	-7.069	0.690	1.695	0.853	-0.662	-0.281
PECE_MAMMARY_STEM_CELL_UP PECE_MAMMARY_STEM_CELL_UP	-3.689	-1.559	-0.407	0.727	-0.407	-1.559	4.819	4.819	-0.407	-0.959	-0.729
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	-0.431	8.062	1.620	0.370	-0.729	-1.191	-0.242	-1.191	-0.431	-1.948	-1.943
SERVITJA_ISLET_HNF1A_TARGETS_UP SERVITJA_ISLET_HNF1A_TARGETS_UP	1.055	-2.833	-1.301	-4.039	0.871	0.434	-0.498	-1.301	0.327	0.706	6.456
LIAN_LIPA_TARGETS_6M LIAN_LIPA_TARGETS_6M	-0.596	-1.707	-2.363	-0.865	-1.225	0.520	-0.865	-0.596	-0.255	1.902	8.395
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	-2.152	-0.595	2.002	5.475	-2.152	-3.072	-0.595	1.287	0.590	0.590	-1.456
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	1.702	1.405	-0.373	1.136	-1.029	-4.192	-1.029	4.529	-0.537	-1.828	-1.023
BROWN_MYELOID_CELL_DEVELOPMENT_UP BROWN_MYELOID_CELL_DEVELOPMENT_UP	-0.621	-1.556	-1.556	-1.901	-1.901	-1.901	-0.261	1.097	0.907	2.632	5.678
LI_DCP2_BOUND_MRNA LI_DCP2_BOUND_MRNA	-1.966	-0.351	2.263	1.264	-0.522	-3.652	1.565	0.759	1.899	-1.448	-2.649
BOYLAN_MULTIPLE_MYELOMA_C_D_UP BOYLAN_MULTIPLE_MYELOMA_C_D_UP	1.097	0.551	3.519	1.846	-1.252	-5.775	0.414	0.301	-1.252	0.301	-1.970
LUI_THYROID_CANCER_PAX8_PPARG_DN LUI_THYROID_CANCER_PAX8_PPARG_DN	-0.702	-1.907	1.677	0.625	-1.907	-1.907	0.625	2.640	2.134	-0.702	-1.901
MIKKELSEN_IPS_LCP_WITH_H3K4ME3 MIKKELSEN_IPS_LCP_WITH_H3K4ME3	0.646	-0.415	-2.952	-4.964	0.392	0.292	-1.382	-0.545	0.801	1.612	4.897
WIERENGA_STAT5A_TARGETS_GROUP1 WIERENGA_STAT5A_TARGETS_GROUP1	1.166	0.578	-0.761	-1.299	-1.661	-5.275	-0.412	-0.566	-0.292	2.982	3.379
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	-1.706	2.261	2.915	0.628	-0.834	-3.904	1.687	0.628	0.628	-1.706	-2.594
BROWNE_INTERFERON_RESPONSIVE_GENES BROWNE_INTERFERON_RESPONSIVE_GENES	-0.885	-0.586	-0.586	-0.885	-1.891	-2.779	-1.891	0.818	2.609	2.609	2.619
LAIHO_COLORECTAL_CANCER_SERRATED_DN LAIHO_COLORECTAL_CANCER_SERRATED_DN	-0.711	0.419	1.644	4.672	-1.392	-3.568	-0.326	1.644	-0.489	-0.489	-2.575
FRASOR_RESPONSE_TO_ESTRADIOL_DN FRASOR_RESPONSE_TO_ESTRADIOL_DN	1.313	-0.559	-1.171	-2.290	-1.643	-0.369	-3.236	0.558	0.243	4.814	1.646
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	-1.367	-0.898	-1.114	0.479	-0.898	-2.831	-1.997	-0.432	2.542	4.966	2.274
WHITFIELD_CELL_CYCLE_M_G1 WHITFIELD_CELL_CYCLE_M_G1	-1.254	2.045	2.368	0.990	-1.254	-3.227	-0.273	3.878	-1.254	-2.043	-0.721
JOHNSTONE_PARVB_TARGETS_2_UP JOHNSTONE_PARVB_TARGETS_2_UP	-1.093	-3.226	-0.360	-0.851	-2.145	-2.637	1.173	3.225	2.872	1.173	0.474
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	-1.803	-1.803	-1.308	-1.308	-0.934	-1.308	-0.652	0.467	2.130	3.880	3.413
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	-0.744	-1.635	-0.282	-3.263	-2.605	0.321	0.594	-0.400	0.768	0.594	7.231
EGUCHI_CELL_CYCLE_RB1_TARGETS EGUCHI_CELL_CYCLE_RB1_TARGETS	0.217	9.398	0.490	-0.911	-0.406	-0.911	-0.406	-0.911	-0.406	-0.911	-0.909
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	1.971	-0.608	-0.468	-1.487	-4.350	-3.677	-0.262	0.451	2.242	1.971	1.074
WAKASUGI_HAVE_ZNF143_BINDING_SITES WAKASUGI_HAVE_ZNF143_BINDING_SITES	-0.348	5.480	0.944	1.652	-0.921	-2.239	-0.578	0.435	-0.578	-1.431	-2.233
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	-0.810	-1.408	-2.947	-1.077	-1.408	-1.408	-0.598	1.447	3.102	2.037	2.738
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	0.395	0.395	-3.165	-1.779	-0.722	-0.420	-2.170	-0.722	0.517	3.162	5.113
BURTON_ADIPOGENESIS_PEAK_AT_16HR BURTON_ADIPOGENESIS_PEAK_AT_16HR	0.749	6.463	2.432	-0.599	-0.599	-1.024	-0.599	-1.024	-1.024	-1.024	-1.736
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP	9.692	-1.392	-1.392	-0.489	0.806	-1.392	0.278	-0.489	-1.392	-0.489	0.280
SCHLOSSER_SERUM_RESPONSE_UP SCHLOSSER_SERUM_RESPONSE_UP	-0.412	-2.637	-0.292	-1.003	-1.661	-2.101	2.982	1.410	4.626	-1.003	0.314
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	-1.393	-0.422	2.425	1.636	-0.961	-2.903	0.342	3.867	-0.264	-0.961	-1.992
ABRAMSON_INTERACT_WITH_AIRE ABRAMSON_INTERACT_WITH_AIRE	0.430	2.807	5.388	-0.373	-1.090	-1.090	-0.650	0.239	-0.650	-1.824	-1.819
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	-0.276	1.961	2.806	2.806	-1.424	-2.945	-0.668	-0.276	0.328	-2.035	-1.418
CERVERA_SDHB_TARGETS_1_UP CERVERA_SDHB_TARGETS_1_UP	1.850	-0.354	-2.477	-0.677	-1.957	-0.496	-2.477	-0.496	0.254	1.563	5.466
VANTVEER_BREAST_CANCER_METASTASIS_DN VANTVEER_BREAST_CANCER_METASTASIS_DN	-0.479	5.428	3.130	0.928	-1.214	-2.071	-0.909	0.392	-0.909	-0.909	-2.061
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	0.301	-1.815	-1.077	-0.810	-2.319	-2.319	0.577	0.577	-0.430	3.102	4.855
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN	0.870	-1.164	-0.885	-2.445	-0.343	-1.164	-0.483	-0.343	-1.164	1.086	8.266
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	1.435	-0.687	-0.903	-1.872	-1.167	1.984	-1.487	-0.687	-1.487	0.340	6.487
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	0.372	-0.390	-0.910	-1.927	-1.927	-0.606	-1.927	-0.390	1.728	0.560	6.483
BASSO_B_LYMPHOCYTE_NETWORK BASSO_B_LYMPHOCYTE_NETWORK	-0.503	6.135	1.150	1.150	-1.756	-3.977	0.338	-0.667	0.338	-0.667	-1.105
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	-0.451	5.560	1.565	1.180	-0.755	-1.990	-0.256	-0.451	-0.755	-1.225	-1.984
GAURNIER_PSMD4_TARGETS GAURNIER_PSMD4_TARGETS	0.328	-2.035	-1.424	-2.035	-0.986	-0.986	-0.276	0.328	-0.276	5.489	2.818
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	0.541	5.545	2.676	-0.260	-1.064	-1.606	0.346	-1.606	-0.691	-1.606	-1.059
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2 BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	-0.961	-0.422	2.872	3.867	-1.999	-1.999	2.012	-0.422	-0.422	-0.961	-1.387
MIKKELSEN_IPS_WITH_HCP_H3K27ME3 MIKKELSEN_IPS_WITH_HCP_H3K27ME3	-0.569	-0.398	-3.220	-0.569	1.080	4.876	-0.270	-3.220	-0.790	0.334	1.639
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	0.277	3.157	1.094	0.479	-2.385	-4.630	-1.114	0.914	-1.659	1.741	0.374
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	0.783	3.700	2.514	0.285	-0.991	-0.574	-0.991	-1.699	-1.699	0.501	-1.695
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	-1.171	1.024	-0.559	-0.820	-1.643	-3.236	-1.171	0.381	1.313	4.814	0.777
SABATES_COLORECTAL_ADENOMA_UP SABATES_COLORECTAL_ADENOMA_UP	1.545	-0.580	-1.608	-3.761	0.693	1.813	-1.274	-3.060	0.693	1.813	1.082
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	0.391	-1.016	0.283	-1.016	-0.784	-4.677	-1.016	-0.320	0.522	3.418	3.824
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	-1.431	-0.578	0.435	0.944	0.664	-1.431	5.480	0.944	-1.431	-0.921	-2.233
BASSO_CD40_SIGNALING_UP BASSO_CD40_SIGNALING_UP	-1.051	-2.432	-1.858	-0.553	-1.858	-1.407	0.667	1.108	3.534	2.709	0.672
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	1.144	-3.653	-1.209	-2.395	0.933	2.214	-0.283	-1.209	-1.209	1.144	2.550
VALK_AML_CLUSTER_5 VALK_AML_CLUSTER_5	-1.326	-1.326	-0.702	-1.326	-1.326	-1.326	0.247	0.793	1.184	2.177	2.779
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	-2.982	-1.136	0.497	0.632	-1.714	-4.211	0.497	2.378	2.096	0.632	0.965
BROWN_MYELOID_CELL_DEVELOPMENT_DN BROWN_MYELOID_CELL_DEVELOPMENT_DN	0.749	6.065	0.432	-0.292	-1.661	-4.136	0.749	-0.412	-0.292	-0.292	-1.652
ZHANG_RESPONSE_TO_CANTHARIDIN_DN ZHANG_RESPONSE_TO_CANTHARIDIN_DN	-1.302	3.079	3.079	1.416	-0.374	-2.779	0.581	-0.586	-0.885	-1.302	-1.296
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	-1.540	-0.869	-0.312	2.114	-2.009	-2.603	0.290	3.665	2.464	-0.312	-1.160
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	-0.385	0.453	5.553	1.577	-1.367	-1.367	0.231	-0.733	0.231	-1.367	-1.364
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	0.997	2.425	4.988	0.519	-1.393	-0.961	-0.422	-1.393	-0.647	-1.393	-1.992
MIKKELSEN_ES_LCP_WITH_H3K4ME3 MIKKELSEN_ES_LCP_WITH_H3K4ME3	-0.638	-0.834	-1.362	-4.793	0.628	0.482	-0.478	-0.638	0.628	0.795	5.823
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	0.513	-1.909	-0.436	-0.759	-2.852	-3.460	0.283	1.457	0.513	2.911	2.285
BOYLAN_MULTIPLE_MYELOMA_D_DN BOYLAN_MULTIPLE_MYELOMA_D_DN	-0.888	-0.888	-0.614	0.502	-1.739	-3.360	-0.888	-0.266	1.209	3.537	2.647
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	-1.211	-1.783	0.274	1.928	-0.810	-1.783	0.906	2.808	2.349	-1.211	-1.777
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	-1.253	1.209	5.104	1.516	-2.400	-2.400	-0.614	0.339	-0.266	-1.253	-0.264
BURTON_ADIPOGENESIS_5 BURTON_ADIPOGENESIS_5	-0.312	-0.443	0.936	3.050	-1.843	-3.790	0.936	1.417	1.163	-1.432	-1.834
WELCSH_BRCA1_TARGETS_UP WELCSH_BRCA1_TARGETS_UP	-3.236	-0.586	1.610	2.092	-0.586	-5.124	1.610	0.692	0.842	-0.586	-0.261
RIZ_ERYTHROID_DIFFERENTIATION RIZ_ERYTHROID_DIFFERENTIATION	-0.278	3.955	1.812	-0.278	-1.280	-3.402	1.477	0.326	-0.633	-1.771	-0.906
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	-0.301	5.977	1.112	0.856	-1.336	-1.836	-1.336	1.112	-1.336	-0.672	-1.329
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	-2.306	1.219	2.663	2.663	-0.499	-2.864	-1.146	1.219	0.477	-0.671	-1.836
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	1.856	-0.614	0.339	2.230	-1.739	-3.360	0.339	3.071	-0.614	-0.888	-1.247
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	-0.412	0.432	1.679	1.166	-1.299	-4.136	0.749	2.982	0.432	-1.003	-2.626
PYEON_HPV_POSITIVE_TUMORS_UP PYEON_HPV_POSITIVE_TUMORS_UP	0.946	2.867	2.477	0.728	-1.768	-3.070	-0.984	1.194	-0.984	-0.984	-1.322
LIAN_LIPA_TARGETS_3M LIAN_LIPA_TARGETS_3M	-1.211	-1.211	-1.783	-0.810	-1.211	0.274	-0.527	-0.527	0.440	2.349	6.297
JIANG_HYPOXIA_NORMAL JIANG_HYPOXIA_NORMAL	-0.264	-0.919	0.442	0.559	-0.586	-6.996	0.341	1.610	0.842	2.636	-1.120
BROWNE_HCMV_INFECTION_14HR_UP BROWNE_HCMV_INFECTION_14HR_UP	-0.636	2.130	0.934	1.851	-0.260	-2.976	-0.823	1.851	0.756	-2.976	-2.001
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	-0.262	0.344	-0.468	-0.776	-1.487	-3.677	-0.776	-0.354	-0.468	3.494	4.626
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	-1.393	-0.422	0.997	4.988	-0.647	-1.999	0.519	1.636	-0.264	-1.393	-1.992
IRITANI_MAD1_TARGETS_DN IRITANI_MAD1_TARGETS_DN	-0.228	1.677	1.677	0.625	-0.411	-1.907	2.640	-0.411	-1.158	-1.907	-1.901
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	-1.792	3.894	1.796	1.796	-2.798	-1.792	0.504	0.504	-0.849	-0.849	-0.635
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	0.991	-3.265	0.991	0.826	-1.393	-4.436	-0.360	0.547	3.203	0.432	-0.268
JAIN_NFKB_SIGNALING JAIN_NFKB_SIGNALING	0.445	1.815	5.187	-0.488	-1.064	-3.070	-0.314	0.288	0.288	-1.064	-1.511
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	0.301	-0.402	-1.308	-0.851	-4.525	-1.594	-0.525	2.083	1.156	3.280	0.977
SANA_RESPONSE_TO_IFNG_UP SANA_RESPONSE_TO_IFNG_UP	0.642	-1.517	-2.144	-1.064	-1.064	-0.732	-1.064	-0.488	1.815	4.613	1.474
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	-0.981	-0.981	-0.473	-2.547	-0.981	-1.364	-0.981	2.034	0.615	2.034	3.751
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	-0.276	-2.065	-0.276	-0.506	-2.065	-2.065	-0.664	-0.276	0.439	2.994	4.924
GAVIN_FOXP3_TARGETS_CLUSTER_T7 GAVIN_FOXP3_TARGETS_CLUSTER_T7	-1.029	1.136	1.405	-0.373	-0.752	-4.192	0.687	1.702	1.702	-0.537	-2.389
DELPUECH_FOXO3_TARGETS_DN DELPUECH_FOXO3_TARGETS_DN	4.494	2.069	1.176	-0.300	-0.549	-1.658	-0.958	-1.658	-0.958	-0.549	-0.546
LY_AGING_OLD_DN LY_AGING_OLD_DN	-0.622	5.239	3.993	-0.622	-0.977	-0.977	0.233	-0.977	-0.977	-0.622	-0.973
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	-1.787	-0.582	-2.913	-1.055	-1.055	-1.383	0.439	2.076	2.771	2.076	0.781
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	-0.869	0.290	1.491	2.464	-0.869	-2.603	0.576	1.789	0.976	-2.603	-2.000
MALONEY_RESPONSE_TO_17AAG_DN MALONEY_RESPONSE_TO_17AAG_DN	-1.144	2.046	1.680	1.350	0.798	-2.253	1.680	-0.797	-0.797	-1.612	-2.245
WHITFIELD_CELL_CYCLE_LITERATURE WHITFIELD_CELL_CYCLE_LITERATURE	-0.373	5.388	2.277	0.430	-1.090	-1.824	0.239	-1.090	-0.650	-0.650	-1.086
TOOKER_GEMCITABINE_RESISTANCE_DN TOOKER_GEMCITABINE_RESISTANCE_DN	2.122	3.577	0.644	-0.510	-1.558	-3.982	-0.694	0.353	1.037	-0.694	-1.201
MOSERLE_IFNA_RESPONSE MOSERLE_IFNA_RESPONSE	-1.326	-0.702	-0.702	0.247	-1.326	-1.326	-1.326	2.771	2.771	0.793	0.482
BURTON_ADIPOGENESIS_6 BURTON_ADIPOGENESIS_6	-1.508	-0.506	-1.508	1.559	-1.815	-4.170	1.144	1.792	1.559	1.144	0.313
LAIHO_COLORECTAL_CANCER_SERRATED_UP LAIHO_COLORECTAL_CANCER_SERRATED_UP	-1.034	-0.405	-0.774	0.795	-2.256	-2.878	1.510	1.246	4.502	-0.567	-0.562
STEARMAN_TUMOR_FIELD_EFFECT_UP STEARMAN_TUMOR_FIELD_EFFECT_UP	-1.533	-0.860	-0.860	-0.860	-0.860	-0.250	-0.860	-0.250	0.614	0.614	7.399
PODAR_RESPONSE_TO_ADAPHOSTIN_UP PODAR_RESPONSE_TO_ADAPHOSTIN_UP	3.400	-1.474	-1.474	0.554	-2.256	-3.359	0.421	0.884	-0.292	1.800	0.559
WONG_PROTEASOME_GENE_MODULE WONG_PROTEASOME_GENE_MODULE	-1.294	1.095	3.991	1.461	-0.810	-2.073	0.781	0.317	-0.810	-1.294	-1.289
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	0.309	-0.293	-2.117	-0.399	-1.731	-3.731	-0.531	1.046	0.858	3.984	1.264
WIERENGA_STAT5A_TARGETS_DN WIERENGA_STAT5A_TARGETS_DN	0.309	0.519	-0.389	-1.815	-2.167	-3.561	-0.647	-0.294	1.559	2.307	2.905
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	-0.652	0.964	-0.360	1.930	-0.652	-4.832	0.612	2.872	-0.490	0.469	-2.134
FOSTER_KDM1A_TARGETS_DN FOSTER_KDM1A_TARGETS_DN	0.559	-1.654	-0.264	1.193	-1.975	-3.779	1.610	1.610	1.393	0.842	-1.962
GEORGES_CELL_CYCLE_MIR192_TARGETS GEORGES_CELL_CYCLE_MIR192_TARGETS	-0.301	4.008	3.461	0.301	-1.152	-2.571	-0.301	-0.489	-1.152	-0.489	-0.758
NAKAMURA_CANCER_MICROENVIRONMENT_DN NAKAMURA_CANCER_MICROENVIRONMENT_DN	2.204	2.722	0.958	0.409	-0.392	-1.865	-0.676	0.409	-0.676	-1.865	-1.860
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	1.706	3.135	0.980	1.319	-1.397	-2.197	-0.893	-0.893	0.272	-0.893	-1.392
CUI_GLUCOSE_DEPRIVATION CUI_GLUCOSE_DEPRIVATION	2.540	0.315	-1.122	-0.738	-1.677	-2.529	-1.122	1.689	2.540	-0.287	-0.285
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	1.277	4.189	1.596	0.538	-1.675	-1.198	0.538	-1.675	-0.842	-0.842	-1.668
LIU_COMMON_CANCER_GENES LIU_COMMON_CANCER_GENES	-1.211	1.928	0.440	0.651	-1.783	-1.783	1.546	0.651	1.546	-2.654	-0.806
WARTERS_IR_RESPONSE_5GY WARTERS_IR_RESPONSE_5GY	0.334	-2.031	-0.782	-0.472	-2.031	-2.031	0.546	0.334	1.137	1.137	2.939
FURUKAWA_DUSP6_TARGETS_PCI35_DN FURUKAWA_DUSP6_TARGETS_PCI35_DN	-0.454	8.024	0.936	0.314	-0.454	-1.455	-0.689	-1.012	-1.012	-1.012	-0.286
ELVIDGE_HYPOXIA_DN ELVIDGE_HYPOXIA_DN	-0.904	0.433	2.420	1.103	0.433	-4.949	1.103	1.325	-0.528	-0.904	-1.797
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	0.728	-2.331	-0.984	-0.506	-0.506	2.477	-3.070	-0.348	-0.714	1.194	2.880
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	-0.865	-1.225	-1.225	-0.255	-2.363	-1.707	-0.596	1.555	0.965	2.282	2.705
KAAB_FAILED_HEART_ATRIUM_DN KAAB_FAILED_HEART_ATRIUM_DN	-1.133	-0.682	0.742	2.786	-0.682	-2.698	-0.515	3.132	0.582	0.582	-2.685
SIMBULAN_PARP1_TARGETS_DN SIMBULAN_PARP1_TARGETS_DN	-0.704	5.288	1.206	-0.704	-0.704	-0.272	0.706	-0.704	-0.704	-0.704	-0.702
SASAKI_ADULT_T_CELL_LEUKEMIA SASAKI_ADULT_T_CELL_LEUKEMIA	-0.813	2.295	1.076	2.295	-1.926	-4.004	-0.486	0.445	0.889	0.336	-1.568
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	-1.868	0.289	-0.981	1.366	-1.364	-3.527	-0.473	2.034	1.366	1.366	0.292
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN	0.561	-1.099	-0.829	-3.790	0.291	0.735	-0.829	-0.829	-0.443	1.417	4.785
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	-0.310	-0.844	-0.672	-1.045	-0.528	-2.217	-1.045	-0.408	-0.310	3.782	4.908
HOLLERN_EMT_BREAST_TUMOR_DN HOLLERN_EMT_BREAST_TUMOR_DN	3.690	-0.885	0.376	-1.928	0.376	-1.508	-0.483	-0.483	-1.508	-0.483	4.135
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	-0.430	0.291	-0.767	-0.311	-2.007	-4.638	-0.580	0.536	1.545	2.414	1.825
RICKMAN_HEAD_AND_NECK_CANCER_E RICKMAN_HEAD_AND_NECK_CANCER_E	0.404	-0.338	-1.933	-1.933	2.712	1.943	-0.505	-1.420	-1.029	-0.731	2.724
HOLLERN_EMT_BREAST_TUMOR_UP HOLLERN_EMT_BREAST_TUMOR_UP	0.693	-0.996	-1.608	0.291	-1.608	-3.060	-0.996	0.403	2.103	1.545	2.761
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	0.524	5.110	2.071	0.371	-0.521	-1.798	-1.798	0.249	-0.360	-1.355	-1.348
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	-0.364	2.602	3.463	1.528	0.376	-1.999	-0.771	-1.077	-0.771	-1.999	-0.766
GREENBAUM_E2A_TARGETS_UP GREENBAUM_E2A_TARGETS_UP	0.754	3.306	2.092	0.754	-1.367	-1.367	-1.367	-0.733	-0.733	-0.385	-0.730
KOBAYASHI_EGFR_SIGNALING_24HR_UP KOBAYASHI_EGFR_SIGNALING_24HR_UP	0.667	-0.771	-0.771	-1.858	-2.432	-1.407	-0.771	0.346	2.334	3.109	1.381
BYSTROEM_CORRELATED_WITH_IL5_DN BYSTROEM_CORRELATED_WITH_IL5_DN	-1.035	-0.416	3.806	1.112	-1.571	-2.405	0.362	1.844	-0.668	-0.247	-1.030
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	0.906	-0.329	-0.810	-1.211	-0.810	-0.329	-1.783	-0.329	-1.783	2.349	4.410
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	-0.732	3.283	-0.732	1.559	-1.155	-2.101	-3.012	0.768	-0.436	2.064	-0.323
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	1.255	4.831	0.997	0.279	-2.264	-2.264	-0.324	-0.940	-1.278	0.412	-0.472
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	-1.756	2.187	1.150	3.547	-1.113	-2.172	0.597	-0.503	0.597	-1.756	-0.862
MIKKELSEN_MEF_LCP_WITH_H3K4ME3 MIKKELSEN_MEF_LCP_WITH_H3K4ME3	-0.301	-0.778	-1.322	-1.687	-1.023	-1.322	-0.581	0.301	0.420	2.934	5.040
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP PACHER_TARGETS_OF_IGF1_AND_IGF2_UP	7.591	-0.828	-0.453	-0.828	-0.453	-0.234	-0.828	-1.492	-0.234	-0.453	0.649
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	0.987	-0.392	-1.901	-1.044	-0.392	-3.808	-0.513	0.409	-0.293	3.664	2.128
RICKMAN_HEAD_AND_NECK_CANCER_D RICKMAN_HEAD_AND_NECK_CANCER_D	-0.266	-0.500	-1.575	-1.575	1.721	4.054	-0.500	-0.893	-0.500	-0.893	1.283
COLDREN_GEFITINIB_RESISTANCE_UP COLDREN_GEFITINIB_RESISTANCE_UP	0.419	2.768	1.052	1.644	-1.901	-2.584	1.052	-0.326	-0.489	-1.901	-0.999
GALE_APL_WITH_FLT3_MUTATED_UP GALE_APL_WITH_FLT3_MUTATED_UP	-0.691	-0.260	1.791	3.716	-1.064	-2.446	1.411	-0.434	-0.434	-0.434	-1.601
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	0.326	-1.280	-1.280	-1.771	-0.278	-0.911	-0.427	-0.911	0.484	1.812	5.603
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	-1.261	0.511	0.251	1.644	-0.950	-1.649	0.511	3.856	0.367	0.251	-3.512
GAVIN_FOXP3_TARGETS_CLUSTER_P3 GAVIN_FOXP3_TARGETS_CLUSTER_P3	-0.594	0.480	0.268	1.140	-3.901	-3.260	-0.594	0.770	0.480	0.480	3.051
MACAEVA_PBMC_RESPONSE_TO_IR MACAEVA_PBMC_RESPONSE_TO_IR	-1.460	-0.585	-1.460	-0.810	-0.810	-1.918	-0.810	1.593	1.593	3.413	1.318
ALCALA_APOPTOSIS ALCALA_APOPTOSIS	-1.933	-0.505	0.782	1.943	-1.420	-3.610	0.782	1.604	0.576	0.576	-0.726
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	3.806	3.806	0.281	-1.872	-0.848	-1.120	0.545	-0.322	-0.848	-1.120	-0.842
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	2.046	-0.355	-2.253	-0.797	-2.253	-0.355	-0.541	-0.541	-0.541	3.338	1.689
HECKER_IFNB1_TARGETS HECKER_IFNB1_TARGETS	-0.854	-0.606	-1.176	-0.854	-0.854	-2.845	-0.418	0.472	1.692	1.692	3.674
RHODES_CANCER_META_SIGNATURE RHODES_CANCER_META_SIGNATURE	-0.527	4.395	0.651	1.546	-1.783	-1.783	0.274	-0.329	0.440	-1.783	-0.806
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	-1.354	2.671	1.028	0.859	-1.633	-4.370	0.350	1.028	0.350	0.706	-1.103
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	-1.872	0.545	0.400	2.283	0.400	-3.829	0.716	1.661	0.545	-1.872	-0.624
HOSHIDA_LIVER_CANCER_SUBCLASS_S2 HOSHIDA_LIVER_CANCER_SUBCLASS_S2	-0.792	0.593	4.435	1.218	-1.055	-2.288	1.479	0.311	-0.792	-1.383	-1.049
IGLESIAS_E2F_TARGETS_UP IGLESIAS_E2F_TARGETS_UP	-1.093	0.348	-0.652	-1.093	-0.652	-1.731	-2.145	1.173	0.612	1.173	4.846
KASLER_HDAC7_TARGETS_1_UP KASLER_HDAC7_TARGETS_1_UP	-0.371	-0.371	-0.278	0.325	-0.978	-5.634	0.425	3.280	1.185	0.829	-0.778
DITTMER_PTHLH_TARGETS_UP DITTMER_PTHLH_TARGETS_UP	-0.992	0.344	0.645	2.199	-2.809	-2.809	0.344	2.547	0.837	-0.537	-0.732
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	1.356	4.160	0.873	-0.406	-0.911	-0.911	-0.911	0.217	-0.406	-0.911	-0.909
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	1.087	0.265	-1.580	-0.775	-0.341	3.408	-1.117	-3.153	0.412	1.387	-0.338
SWEET_KRAS_TARGETS_UP SWEET_KRAS_TARGETS_UP	-0.289	-0.442	-1.803	0.313	-0.652	-3.444	-0.442	0.883	0.313	0.657	4.406
TANG_SENESCENCE_TP53_TARGETS_DN TANG_SENESCENCE_TP53_TARGETS_DN	0.397	5.239	2.405	-0.622	-0.977	-1.501	-0.382	-0.382	-0.622	-0.977	-0.973
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	-1.858	-0.301	-0.413	2.661	-1.497	-2.790	-0.554	-0.301	2.998	1.275	-0.298
BIDUS_METASTASIS_DN BIDUS_METASTASIS_DN	-1.960	-0.791	0.629	0.266	-2.914	-2.397	2.503	0.629	0.367	1.649	0.982
IKEDA_MIR30_TARGETS_UP IKEDA_MIR30_TARGETS_UP	-1.383	0.439	0.593	4.905	-1.787	-2.913	0.439	0.593	0.439	-0.291	-0.786
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	-1.855	2.231	-0.566	0.846	-0.359	-2.737	2.673	0.405	0.405	-0.860	-0.855
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	1.856	-2.400	-0.614	-2.400	0.339	0.937	-0.888	-1.253	0.701	0.339	2.647
DER_IFN_BETA_RESPONSE_UP DER_IFN_BETA_RESPONSE_UP	-1.434	0.648	2.658	-0.790	-0.790	-4.276	-0.270	1.080	0.476	1.080	-0.395
MAYBURD_RESPONSE_TO_L663536_DN MAYBURD_RESPONSE_TO_L663536_DN	-0.949	1.601	1.232	1.601	-1.466	-1.466	1.232	0.637	-0.949	-0.365	-2.274
GERY_CEBP_TARGETS GERY_CEBP_TARGETS	0.860	0.273	-1.766	0.518	-2.766	-1.766	-0.831	-0.625	1.067	1.298	3.176
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	1.559	0.617	-0.436	-1.155	1.559	-1.155	-3.012	-2.101	0.617	-0.327	2.656
YAGI_AML_FAB_MARKERS YAGI_AML_FAB_MARKERS	-0.528	0.386	-0.844	-0.310	-0.844	-4.947	-0.844	0.926	0.622	1.983	2.538
MILI_PSEUDOPODIA_CHEMOTAXIS_UP MILI_PSEUDOPODIA_CHEMOTAXIS_UP	-0.711	1.988	0.806	1.988	-0.711	-3.568	1.331	0.278	-0.489	-0.711	-1.385
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP	-0.424	-3.333	-0.581	0.731	-0.778	-2.669	-0.301	0.301	1.140	1.935	2.259
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	-0.234	0.646	5.060	0.646	-0.828	-1.492	0.380	-0.828	-0.828	-1.492	-0.233
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	0.612	1.957	-0.382	1.551	-2.322	-1.501	0.233	0.233	1.190	-0.382	-2.315
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	1.653	-0.875	-1.201	-0.432	-0.624	-0.875	-1.621	-1.201	-0.290	1.985	4.078
SMID_BREAST_CANCER_LUMINAL_A_UP SMID_BREAST_CANCER_LUMINAL_A_UP	3.267	-1.364	-1.868	-0.981	0.289	0.615	-0.313	-2.547	0.289	0.435	2.044
THILLAINADESAN_ZNF217_TARGETS_UP THILLAINADESAN_ZNF217_TARGETS_UP	0.783	1.997	1.129	1.129	-1.699	-1.699	-0.991	-0.574	0.501	0.285	-1.695
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	0.906	-1.211	-0.329	-1.783	-0.329	-1.783	-0.810	0.440	-0.810	3.302	2.359
ALONSO_METASTASIS_UP ALONSO_METASTASIS_UP	-2.597	0.781	1.124	2.012	-1.260	-3.592	0.396	0.635	0.781	0.944	-1.019
SANA_TNF_SIGNALING_UP SANA_TNF_SIGNALING_UP	-0.301	-1.336	-1.336	-0.458	-1.836	-0.672	-1.336	0.451	1.402	3.332	2.092
KERLEY_RESPONSE_TO_CISPLATIN_UP KERLEY_RESPONSE_TO_CISPLATIN_UP	0.409	-1.124	-0.676	-1.124	-1.124	-0.676	-0.676	-1.124	0.958	2.722	3.298
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	-0.310	-0.687	-1.079	-0.536	-1.079	-2.775	-0.310	0.950	-0.687	2.918	3.596
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	0.629	4.801	0.827	1.053	-1.918	-1.460	-0.280	-0.411	-1.918	-0.585	-0.580
ROSS_AML_WITH_PML_RARA_FUSION ROSS_AML_WITH_PML_RARA_FUSION	0.339	-0.614	-1.253	-0.266	-2.400	-2.400	-0.266	0.937	2.635	-0.266	2.240
LIANG_SILENCED_BY_METHYLATION_UP LIANG_SILENCED_BY_METHYLATION_UP	2.092	-0.385	-1.367	-0.733	-1.367	0.754	-1.367	0.231	-0.733	0.453	2.677
LIANG_SILENCED_BY_METHYLATION_2 LIANG_SILENCED_BY_METHYLATION_2	-1.064	-0.691	-2.446	-1.606	1.075	0.541	-1.064	-0.260	0.541	1.411	2.686
MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD	1.272	-0.694	-2.509	-0.924	1.037	-1.558	-1.558	-0.255	0.353	0.828	3.595
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	6.742	0.362	-0.247	-0.247	-0.663	-0.663	-0.663	-0.247	-0.247	-0.663	-0.661
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	-0.546	-1.241	3.226	2.740	-1.241	-1.819	-0.344	1.168	-0.344	-0.546	-0.831
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	0.967	-0.983	-2.072	-2.072	0.967	1.712	-0.282	-1.635	-0.983	1.440	1.723
TAKAO_RESPONSE_TO_UVB_RADIATION_UP TAKAO_RESPONSE_TO_UVB_RADIATION_UP	-0.731	-1.029	-0.505	0.576	-0.731	-2.621	3.140	2.712	0.782	-0.731	-0.726
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	1.320	-0.676	-1.124	0.226	-0.392	-0.676	-1.124	-1.865	-0.392	1.320	3.910
ROSS_AML_WITH_CBFB_MYH11_FUSION ROSS_AML_WITH_CBFB_MYH11_FUSION	-0.316	-0.535	0.286	-0.535	-1.362	-2.156	-0.865	-0.316	0.476	1.017	5.065
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	-0.247	-0.663	-0.663	-0.663	1.939	1.939	1.939	-0.663	-0.663	-0.663	-0.661
WILENSKY_RESPONSE_TO_DARAPLADIB WILENSKY_RESPONSE_TO_DARAPLADIB	-1.160	-0.580	-0.580	0.324	-1.160	-1.160	-1.160	0.978	0.607	1.432	2.572
SASSON_RESPONSE_TO_FORSKOLIN_DN SASSON_RESPONSE_TO_FORSKOLIN_DN	-0.981	-1.364	0.831	1.366	-1.868	-2.547	-0.313	3.267	0.289	0.435	0.438
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN	0.845	0.587	-1.536	-1.006	-1.006	-0.399	-1.006	-0.645	-1.006	1.900	3.911
PARK_HSC_AND_MULTIPOTENT_PROGENITORS PARK_HSC_AND_MULTIPOTENT_PROGENITORS	-0.392	0.409	1.736	1.320	-1.865	-1.124	1.320	-0.392	0.958	-1.865	-1.120
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	-1.650	1.318	1.615	0.441	-1.227	-3.943	0.441	1.052	0.441	0.441	-0.637
STEIN_ESRRA_TARGETS_DN STEIN_ESRRA_TARGETS_DN	-1.143	1.524	1.249	0.593	-1.143	-4.400	-0.438	1.249	0.783	-0.301	-0.434
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	-0.482	-0.823	-0.636	-0.636	-1.048	-2.455	-0.636	0.599	0.347	2.130	4.621
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	0.376	-0.538	-0.771	-2.696	-0.771	0.736	-1.477	0.376	0.246	0.539	4.974
BASSO_CD40_SIGNALING_DN BASSO_CD40_SIGNALING_DN	-0.438	-0.438	0.328	-0.668	-2.945	-1.424	-0.986	1.592	0.328	1.961	1.970
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	1.690	-0.363	-2.203	-1.830	-0.363	-0.270	-0.791	-1.830	0.564	1.690	2.814
MORI_PRE_BI_LYMPHOCYTE_UP MORI_PRE_BI_LYMPHOCYTE_UP	-0.266	5.104	1.209	0.701	-1.739	-0.614	0.339	-0.412	-0.888	-1.253	-1.247
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	1.416	0.388	-0.586	0.238	-1.302	-2.779	-0.885	4.121	0.238	0.238	-0.372
MUELLER_METHYLATED_IN_GLIOBLASTOMA MUELLER_METHYLATED_IN_GLIOBLASTOMA	0.453	-1.782	-0.354	-1.782	0.715	2.353	-1.057	-0.354	-1.057	0.453	1.869
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	-0.992	0.837	-0.262	0.837	-0.262	-4.692	1.875	0.837	0.645	-0.381	-1.302
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	-0.520	-1.077	0.371	-1.077	-0.520	-1.077	-1.077	0.684	0.371	3.507	1.092
QI_HYPOXIA QI_HYPOXIA	2.092	0.264	0.264	0.372	-2.798	-1.792	-1.104	0.840	-0.342	3.111	-0.842
VILIMAS_NOTCH1_TARGETS_DN VILIMAS_NOTCH1_TARGETS_DN	-1.119	-0.550	-0.550	-1.119	-0.550	-0.550	-0.260	0.347	1.503	-0.550	4.960
LUI_THYROID_CANCER_CLUSTER_3 LUI_THYROID_CANCER_CLUSTER_3	-0.580	-1.160	0.978	0.978	-0.580	-1.160	1.432	1.962	0.324	-1.160	-1.157
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	-1.243	1.796	2.361	0.880	-0.320	-1.243	0.283	0.283	-0.320	-1.243	-1.240
LEE_LIVER_CANCER_ACOX1_DN LEE_LIVER_CANCER_ACOX1_DN	0.876	0.262	-1.241	-1.241	-0.835	0.422	0.876	-2.696	-0.835	1.876	1.885
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	-0.228	1.677	3.193	0.625	-0.411	-1.907	-0.702	-0.411	-0.702	0.389	-1.901
WONG_ENDMETRIUM_CANCER_DN WONG_ENDMETRIUM_CANCER_DN	1.024	-1.171	-0.369	-1.171	-0.559	2.389	-1.643	-0.820	-0.369	-0.559	3.769
PETROVA_PROX1_TARGETS_UP PETROVA_PROX1_TARGETS_UP	2.916	2.916	0.398	-0.491	-0.491	-0.491	-0.491	-1.036	-1.036	-1.036	-0.221
SEKI_INFLAMMATORY_RESPONSE_LPS_DN SEKI_INFLAMMATORY_RESPONSE_LPS_DN	0.490	0.490	-0.406	-0.911	-0.911	0.217	-0.911	-0.911	-0.911	1.356	3.346
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	-0.640	-1.243	-0.640	-0.320	-1.243	-1.243	0.283	1.796	-0.320	2.991	0.884
BEIER_GLIOMA_STEM_CELL_DN BEIER_GLIOMA_STEM_CELL_DN	0.604	-1.271	-0.860	0.405	-1.271	-2.737	-0.566	1.132	0.250	1.132	2.684
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	-1.367	-0.385	2.669	0.754	-0.733	-1.367	1.577	0.754	-0.385	-0.385	-1.364
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN	0.848	-0.755	-1.990	-1.225	-1.225	-0.755	-0.755	1.180	0.848	0.848	2.493
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	-0.222	-1.036	1.149	-0.222	-1.036	-1.036	1.658	1.658	0.726	-1.036	-1.033
LIM_MAMMARY_LUMINAL_PROGENITOR_UP LIM_MAMMARY_LUMINAL_PROGENITOR_UP	2.747	-1.035	-2.405	-1.571	-0.247	-0.416	0.362	-0.668	0.362	0.362	2.284
SENESE_HDAC2_TARGETS_DN SENESE_HDAC2_TARGETS_DN	2.092	-0.641	-1.104	-0.641	0.264	-1.104	-1.792	-1.416	0.264	2.411	2.425
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	-2.798	0.840	0.264	0.660	-0.473	-4.328	0.660	0.840	1.522	0.372	0.267
KIM_ALL_DISORDERS_DURATION_CORR_DN KIM_ALL_DISORDERS_DURATION_CORR_DN	-1.093	0.469	0.348	3.225	-0.652	-2.637	0.469	0.964	1.404	-0.652	-2.134
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	-0.316	-0.865	0.476	1.761	-0.865	-2.156	1.017	2.690	0.286	-1.362	-0.861
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	-0.782	-0.472	0.334	2.929	-0.782	-2.031	0.814	0.814	0.814	-0.271	-2.026
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3	1.079	-0.765	-0.765	-1.409	0.216	1.512	-0.765	-0.765	-1.409	0.716	2.579
YAGI_AML_SURVIVAL YAGI_AML_SURVIVAL	-0.710	0.808	1.500	-0.377	-0.943	-5.150	-0.264	-0.377	0.808	1.244	0.476
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	0.533	0.282	-1.739	1.864	-0.813	-4.251	-0.321	-0.321	0.282	1.583	1.099
SESTO_RESPONSE_TO_UV_C5 SESTO_RESPONSE_TO_UV_C5	0.625	0.389	0.920	0.920	-0.411	-1.907	0.920	1.271	-0.411	-1.907	-1.901
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	-1.027	1.076	0.889	2.295	-1.578	-4.004	-0.366	0.574	0.445	0.889	-0.806
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	-0.614	-1.739	-0.412	-0.614	-0.888	-1.739	0.502	1.516	4.554	0.502	-0.409
DURAND_STROMA_NS_UP DURAND_STROMA_NS_UP	-0.475	-0.798	0.345	-0.621	-1.261	-1.901	-0.475	-0.475	1.534	5.651	-0.258
CHUNG_BLISTER_CYTOTOXICITY_UP CHUNG_BLISTER_CYTOTOXICITY_UP	-1.209	0.745	-0.283	2.536	-1.209	-3.653	1.914	0.745	-0.283	-0.396	-0.534
SESTO_RESPONSE_TO_UV_C1 SESTO_RESPONSE_TO_UV_C1	-1.091	2.559	1.119	1.769	-0.753	-1.549	0.620	0.276	-1.091	0.276	-2.172
JIANG_AGING_HYPOTHALAMUS_DN JIANG_AGING_HYPOTHALAMUS_DN	-0.430	-1.450	-0.430	0.403	-0.796	-0.796	0.403	6.032	-0.219	-0.796	-0.217
FINETTI_BREAST_CANCER_KINOME_RED FINETTI_BREAST_CANCER_KINOME_RED	0.762	2.696	0.762	1.292	-0.663	-0.663	-0.663	-0.663	-0.663	-0.663	-0.661
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	-0.566	1.825	2.673	1.132	0.250	-1.271	-0.566	-0.359	0.250	-2.737	-0.855
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN	4.353	-0.355	-1.612	-1.144	0.253	1.055	-0.797	-1.612	-0.797	0.578	0.803
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	-0.893	-0.556	0.272	2.616	-0.556	-0.332	3.135	0.455	-0.893	-0.556	-2.191
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP	-0.284	-0.284	-1.153	-0.697	-1.452	-2.728	0.433	1.832	-0.697	2.116	2.129
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	-0.282	-0.282	0.321	0.768	-1.277	-5.233	0.967	0.594	1.440	0.594	-0.547
JIANG_VHL_TARGETS JIANG_VHL_TARGETS	-0.489	1.331	0.278	1.644	-0.489	-3.568	1.331	0.806	0.278	-1.005	-1.385
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	-1.152	-1.152	-1.152	0.478	-1.152	-0.301	-1.152	0.301	0.970	0.701	4.605
LINDSTEDT_DENDRITIC_CELL_MATURATION_D LINDSTEDT_DENDRITIC_CELL_MATURATION_D	0.301	-1.152	-0.301	-1.152	-0.762	-2.571	-0.489	0.301	1.640	2.474	1.290
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	-1.284	0.509	1.241	2.878	-0.671	-1.284	0.836	-0.341	0.264	-0.671	-1.281
GENTILE_UV_LOW_DOSE_DN GENTILE_UV_LOW_DOSE_DN	0.651	2.808	-0.527	0.274	-0.810	-1.211	-0.329	0.440	1.928	-0.810	-2.647
MISSIAGLIA_REGULATED_BY_METHYLATION_UP MISSIAGLIA_REGULATED_BY_METHYLATION_UP	-0.400	-1.277	-2.072	-0.400	-2.072	-0.400	0.321	-0.282	3.031	2.327	0.775
FOSTER_TOLERANT_MACROPHAGE_UP FOSTER_TOLERANT_MACROPHAGE_UP	1.560	0.355	-0.608	-0.782	-3.291	-2.277	0.468	0.355	0.260	2.670	0.761
SASSON_RESPONSE_TO_GONADOTROPHINS_DN SASSON_RESPONSE_TO_GONADOTROPHINS_DN	-1.005	-0.711	0.595	0.595	-2.584	-2.584	0.595	2.768	0.419	0.595	0.423
GRABARCZYK_BCL11B_TARGETS_UP GRABARCZYK_BCL11B_TARGETS_UP	-0.888	-0.412	-0.888	0.502	-0.888	-2.400	-0.412	2.635	3.071	-0.614	0.505
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	-0.893	-0.893	-0.332	-0.332	-0.556	-2.197	-0.332	-0.556	0.980	4.295	0.985
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	-0.731	-0.338	-1.029	-0.505	1.297	1.943	-0.338	-3.610	0.267	-0.338	1.953
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2 DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	-0.301	1.190	2.037	2.368	-0.598	-1.077	-0.301	-1.815	-0.810	-2.319	0.761
ZHAN_V2_LATE_DIFFERENTIATION_GENES ZHAN_V2_LATE_DIFFERENTIATION_GENES	-0.392	2.722	0.958	-0.676	-0.676	-1.865	-0.676	0.409	2.204	-0.676	-1.120
GROSS_HYPOXIA_VIA_HIF1A_UP GROSS_HYPOXIA_VIA_HIF1A_UP	-0.541	1.350	2.875	0.578	-0.355	-3.194	0.578	0.253	-0.355	-0.541	-1.605
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	-0.668	-0.986	-2.035	-0.438	-0.668	-0.986	0.328	2.366	3.786	-0.276	0.330
CAFFAREL_RESPONSE_TO_THC_DN CAFFAREL_RESPONSE_TO_THC_DN	-1.326	1.184	2.177	1.184	-1.326	-1.326	-0.363	-0.702	0.480	0.480	-0.699
WARTERS_RESPONSE_TO_IR_SKIN WARTERS_RESPONSE_TO_IR_SKIN	-0.427	0.326	-0.633	0.326	-3.402	-1.771	-0.633	0.679	1.176	1.812	1.183
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	-0.921	-0.274	-0.274	3.675	-0.703	-3.617	-0.274	1.666	0.330	0.330	-0.697
KIM_GLIS2_TARGETS_UP KIM_GLIS2_TARGETS_UP	0.451	-1.836	-0.672	-1.336	-1.336	-0.458	-0.458	-0.301	0.451	2.468	3.346
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	1.083	-0.599	-1.741	-0.599	0.749	4.242	-0.336	-1.024	-0.336	-1.024	0.271
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	-0.310	-0.893	-0.415	3.721	-0.545	-3.516	0.392	0.646	0.292	-1.118	1.392
RUIZ_TNC_TARGETS_UP RUIZ_TNC_TARGETS_UP	-0.636	-1.636	-1.048	-0.260	-1.318	-0.636	-1.318	0.934	0.599	2.745	2.761
AMIT_EGF_RESPONSE_60_HELA AMIT_EGF_RESPONSE_60_HELA	-0.729	0.370	0.370	0.597	-0.729	-1.948	-1.948	2.066	0.597	-0.729	1.627
SERVITJA_LIVER_HNF1A_TARGETS_DN SERVITJA_LIVER_HNF1A_TARGETS_DN	0.615	-2.250	-0.767	-2.250	0.480	2.708	0.364	-1.852	0.615	0.615	1.149
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	1.082	-0.691	-1.868	-1.868	0.435	0.615	-0.313	-1.868	0.435	0.435	3.281
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	0.292	-0.556	-0.923	-1.446	-0.923	-0.923	-1.779	0.395	1.207	2.212	3.180
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	-1.766	0.677	0.677	3.545	-0.331	-2.218	0.860	0.518	0.384	-1.084	-1.384
AFFAR_YY1_TARGETS_UP AFFAR_YY1_TARGETS_UP	1.439	0.270	-1.929	-0.437	-1.095	0.721	-2.705	-0.712	2.151	-0.334	1.912
CASTELLANO_NRAS_TARGETS_UP CASTELLANO_NRAS_TARGETS_UP	-1.012	-0.454	-0.689	-0.454	-1.455	-0.689	-0.689	0.936	-0.454	5.386	0.941
CHICAS_RB1_TARGETS_LOW_SERUM CHICAS_RB1_TARGETS_LOW_SERUM	0.849	2.658	0.648	-0.270	-0.398	-1.434	-0.398	0.476	1.080	-1.434	-3.209
MULLIGHAN_NPM1_SIGNATURE_3_DN MULLIGHAN_NPM1_SIGNATURE_3_DN	-0.556	-0.310	-0.310	1.430	-0.923	-5.496	0.395	0.517	1.430	0.822	0.296
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6 MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	-0.729	0.370	0.883	3.688	-1.191	-1.948	-0.242	0.883	-1.191	-0.431	-0.240
GOLUB_ALL_VS_AML_DN GOLUB_ALL_VS_AML_DN	-0.953	-0.953	0.199	0.199	-0.953	-0.953	-0.953	0.457	0.821	1.835	1.840
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	-0.418	-0.418	0.892	-0.301	-0.301	-3.725	-0.751	3.913	0.414	0.710	-0.970
LIU_VMYB_TARGETS_UP LIU_VMYB_TARGETS_UP	0.610	-0.727	-0.538	1.470	-2.043	-3.227	-0.388	1.218	1.746	0.788	-0.533
SUNG_METASTASIS_STROMA_DN SUNG_METASTASIS_STROMA_DN	0.258	3.053	2.543	0.258	-2.239	-0.348	-0.578	-0.921	-0.348	-0.921	-0.346
KAMIKUBO_MYELOID_CEBPA_NETWORK KAMIKUBO_MYELOID_CEBPA_NETWORK	-0.640	-1.243	-0.640	-0.320	-1.243	0.283	-0.320	0.539	-0.320	0.283	5.262
SMITH_TERT_TARGETS_UP SMITH_TERT_TARGETS_UP	1.656	0.469	0.777	1.930	-1.093	-3.940	0.348	-0.490	0.777	-1.093	-0.646
GOLDRATH_IMMUNE_MEMORY GOLDRATH_IMMUNE_MEMORY	2.808	-0.329	-0.527	0.274	-1.211	-2.654	-0.810	-0.810	0.906	1.205	0.655
VANTVEER_BREAST_CANCER_ESR1_UP VANTVEER_BREAST_CANCER_ESR1_UP	0.582	-0.886	-0.682	1.126	-2.698	-3.293	0.445	0.582	0.742	1.351	0.931
WENDT_COHESIN_TARGETS_UP WENDT_COHESIN_TARGETS_UP	-1.326	0.247	1.184	2.771	-0.363	-1.326	0.480	0.793	-0.363	-0.702	-1.322
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	0.892	2.211	2.211	-0.199	-0.580	-0.580	-0.580	-0.580	-0.580	-0.580	-0.578
HOWLIN_PUBERTAL_MAMMARY_GLAND HOWLIN_PUBERTAL_MAMMARY_GLAND	-0.885	-0.586	-1.302	-1.302	0.818	0.388	0.388	-1.891	-0.374	2.609	2.183
DAIRKEE_CANCER_PRONE_RESPONSE_BPA DAIRKEE_CANCER_PRONE_RESPONSE_BPA	-0.513	2.767	2.270	0.301	-0.837	-2.114	0.750	-0.513	-0.301	-0.837	-0.833
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	-0.640	2.361	-0.320	0.539	-1.243	-1.243	0.539	1.796	-0.640	-1.243	0.284
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	0.876	1.876	-0.344	0.876	-1.241	-2.696	-1.819	1.168	-0.344	0.262	0.264
YU_MYC_TARGETS_DN YU_MYC_TARGETS_DN	-2.446	-0.260	-0.691	-0.434	-0.260	-1.064	-0.691	-0.434	2.213	0.784	2.686
BOYLAN_MULTIPLE_MYELOMA_C_UP BOYLAN_MULTIPLE_MYELOMA_C_UP	-0.451	1.180	1.565	-0.256	-1.990	-1.225	2.001	-0.451	-0.755	0.848	-1.221
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	1.553	3.545	0.518	-0.461	-1.392	-0.625	-0.831	-1.084	-0.461	-1.766	1.307
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	0.720	-0.535	-2.156	-0.865	-0.316	0.286	-2.156	0.286	0.720	1.017	2.212
OKUMURA_INFLAMMATORY_RESPONSE_LPS OKUMURA_INFLAMMATORY_RESPONSE_LPS	1.025	3.407	0.551	0.326	-0.278	-3.742	-0.806	-0.491	0.691	-0.373	-1.240
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	-1.130	1.843	3.567	-1.373	-0.739	-2.342	0.559	-0.264	0.692	-0.586	-0.347
GAJATE_RESPONSE_TO_TRABECTEDIN_DN GAJATE_RESPONSE_TO_TRABECTEDIN_DN	1.521	2.866	0.256	0.256	-0.828	-0.828	-0.351	-0.828	0.566	-0.828	-0.826
HARRIS_BRAIN_CANCER_PROGENITORS HARRIS_BRAIN_CANCER_PROGENITORS	0.453	-0.354	-0.624	-0.624	0.254	1.423	-1.782	-1.057	-0.354	-0.624	4.135
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	-0.316	-0.535	2.690	1.364	-1.362	-2.156	-0.865	1.364	0.286	-0.535	-0.314
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN	0.339	-0.500	-0.893	-0.500	-0.500	3.391	-0.500	-0.893	-1.575	0.339	2.230
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	-0.610	-0.610	-1.202	-0.610	-0.610	-1.202	-0.300	-0.300	1.365	1.877	2.467
SEIDEN_ONCOGENESIS_BY_MET SEIDEN_ONCOGENESIS_BY_MET	-0.538	1.528	1.231	0.967	-0.771	-2.696	1.528	0.246	0.376	-0.771	-1.991
WORSCHECH_TUMOR_REJECTION_UP WORSCHECH_TUMOR_REJECTION_UP	-0.301	-1.712	-1.712	-0.762	0.701	-0.301	0.301	-1.152	0.478	0.701	4.022
MODY_HIPPOCAMPUS_PRENATAL MODY_HIPPOCAMPUS_PRENATAL	-0.650	0.239	1.798	1.370	-1.090	-1.824	2.277	0.239	-1.090	-0.650	-0.371
JI_RESPONSE_TO_FSH_DN JI_RESPONSE_TO_FSH_DN	-0.893	0.691	2.139	2.616	-0.332	-2.197	-0.893	0.272	-0.893	-0.556	0.274
DAUER_STAT3_TARGETS_DN DAUER_STAT3_TARGETS_DN	-0.755	-0.451	-0.755	-0.256	-1.225	-1.225	-1.225	0.351	1.180	3.588	1.185
LINDSTEDT_DENDRITIC_CELL_MATURATION_B LINDSTEDT_DENDRITIC_CELL_MATURATION_B	-0.271	-0.472	-0.271	0.546	-0.782	-2.031	-2.031	0.334	1.512	2.411	0.336
LUI_TARGETS_OF_PAX8_PPARG_FUSION LUI_TARGETS_OF_PAX8_PPARG_FUSION	-0.765	-0.765	1.079	1.079	-0.765	-1.409	1.079	1.512	0.716	-0.765	-1.405
AMIT_EGF_RESPONSE_480_HELA AMIT_EGF_RESPONSE_480_HELA	0.492	-0.581	1.870	-1.490	-0.752	-3.228	0.965	0.965	-0.581	1.870	-0.576
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	-0.634	0.429	-1.010	-0.806	-2.229	-1.854	0.551	0.551	1.433	0.429	3.427
HASLINGER_B_CLL_WITH_6Q21_DELETION HASLINGER_B_CLL_WITH_6Q21_DELETION	3.338	1.356	-0.406	0.490	-0.406	-0.911	-0.911	0.217	0.217	-0.911	-0.909
BASSO_HAIRY_CELL_LEUKEMIA_UP BASSO_HAIRY_CELL_LEUKEMIA_UP	-0.842	0.538	-0.577	0.367	-1.198	-0.842	-1.675	-0.244	0.538	5.290	-0.242
WOOD_EBV_EBNA1_TARGETS_UP WOOD_EBV_EBNA1_TARGETS_UP	-0.493	0.905	0.526	0.526	-1.622	-4.567	1.394	0.526	0.261	0.380	0.383
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	-0.392	-1.124	-0.676	-1.865	-1.124	0.226	0.409	1.320	-0.392	0.654	3.298
BORCZUK_MALIGNANT_MESOTHELIOMA_DN BORCZUK_MALIGNANT_MESOTHELIOMA_DN	0.432	-1.514	-0.438	-1.979	0.432	-0.617	-1.514	-0.301	0.783	1.002	3.743
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP	-0.373	-0.373	-0.373	-0.373	-0.373	-0.373	-0.373	-0.373	-0.373	2.229	3.250
CHEBOTAEV_GR_TARGETS_DN CHEBOTAEV_GR_TARGETS_DN	5.087	-1.003	-2.637	-0.761	0.311	-0.412	-0.292	-0.566	0.311	0.432	0.583
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	0.239	0.684	0.684	0.430	0.684	-1.824	0.684	1.798	-1.090	-1.824	-1.086
BOSCO_TH1_CYTOTOXIC_MODULE BOSCO_TH1_CYTOTOXIC_MODULE	1.032	-2.225	-1.334	-0.552	-0.756	0.333	-0.756	-0.552	0.628	0.628	4.130
LE_EGR2_TARGETS_DN LE_EGR2_TARGETS_DN	-0.291	-1.487	-1.949	-0.424	-0.601	-1.949	0.447	0.611	1.027	2.945	1.034
PARK_APL_PATHOGENESIS_DN PARK_APL_PATHOGENESIS_DN	-0.755	-0.755	0.351	-0.451	-1.225	-1.990	-0.755	0.571	1.565	0.848	2.493
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	-0.787	1.057	1.613	0.279	-0.324	-0.787	-0.324	2.269	-0.787	-0.787	-0.785
PROVENZANI_METASTASIS_DN PROVENZANI_METASTASIS_DN	-1.035	0.380	-1.318	0.509	-3.126	0.274	0.509	3.752	-0.330	-0.453	0.840
WOO_LIVER_CANCER_RECURRENCE_UP WOO_LIVER_CANCER_RECURRENCE_UP	1.279	-1.120	-0.829	0.312	-1.949	-1.487	-1.120	0.611	0.447	2.559	1.287
DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	1.509	-0.872	-0.518	-1.105	-0.388	0.877	-1.707	-1.707	0.428	0.318	3.676
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	0.590	-1.192	-0.761	0.261	-1.784	0.261	-1.466	-0.345	-0.458	2.566	3.217
MEBARKI_HCC_PROGENITOR_WNT_DN MEBARKI_HCC_PROGENITOR_WNT_DN	-0.268	-0.268	-0.404	-1.151	0.889	-0.268	-2.807	-1.151	0.336	0.672	3.741
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	2.916	-0.491	-1.036	-1.036	0.398	0.726	-0.222	-1.036	-1.036	0.398	0.729
JACKSON_DNMT1_TARGETS_UP JACKSON_DNMT1_TARGETS_UP	-0.278	0.484	0.326	1.477	-2.436	-2.436	-0.427	-0.911	0.484	2.179	0.488
DIRMEIER_LMP1_RESPONSE_LATE_UP DIRMEIER_LMP1_RESPONSE_LATE_UP	0.877	-0.977	0.397	0.233	-2.322	-2.322	0.397	1.190	0.612	1.190	-0.379
ZHAN_MULTIPLE_MYELOMA_PR_DN ZHAN_MULTIPLE_MYELOMA_PR_DN	-1.259	-0.782	0.546	0.814	-0.271	-2.031	0.334	-1.259	2.929	-0.271	0.818
MELLMAN_TUT1_TARGETS_UP MELLMAN_TUT1_TARGETS_UP	0.256	1.521	0.256	2.148	-0.828	-0.828	-0.351	0.991	-0.828	-0.828	-0.826
RASHI_RESPONSE_TO_IONIZING_RADIATION_5 RASHI_RESPONSE_TO_IONIZING_RADIATION_5	0.264	2.092	1.271	0.504	-2.247	-2.247	-0.342	0.372	1.044	0.372	-1.783
SUNG_METASTASIS_STROMA_UP SUNG_METASTASIS_STROMA_UP	0.542	-0.334	-1.595	1.163	-0.909	-2.071	-0.479	-0.668	0.270	3.982	0.547
EINAV_INTERFERON_SIGNATURE_IN_CANCER EINAV_INTERFERON_SIGNATURE_IN_CANCER	-1.119	-0.550	-0.260	-0.550	-1.119	-1.119	-0.550	1.032	2.052	1.503	0.647
BROWNE_HCMV_INFECTION_18HR_UP BROWNE_HCMV_INFECTION_18HR_UP	-1.100	2.160	1.639	1.191	-2.026	-1.362	-0.405	1.406	-0.301	-1.100	-0.683
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	2.771	-0.702	0.247	-1.326	0.247	1.184	-1.326	-0.702	-0.702	-0.363	1.189
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT	3.079	-0.522	-1.448	0.390	1.565	-1.448	-1.053	-1.448	0.256	0.256	1.001
GAJATE_RESPONSE_TO_TRABECTEDIN_UP GAJATE_RESPONSE_TO_TRABECTEDIN_UP	1.458	0.405	-0.359	-1.271	-0.566	-1.271	-0.860	-0.566	-0.860	4.210	0.607
MEISSNER_NPC_HCP_WITH_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K27ME3	0.538	-1.675	-1.675	-1.675	0.994	2.753	0.538	-1.198	0.367	0.367	0.542
ROSS_LEUKEMIA_WITH_MLL_FUSIONS ROSS_LEUKEMIA_WITH_MLL_FUSIONS	-0.865	-0.255	-0.397	0.520	-0.865	-3.319	-0.255	2.282	1.243	0.965	-0.592
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN	-0.477	0.614	1.788	-0.860	-1.533	-0.860	-1.533	1.332	0.614	-0.477	0.944
RODRIGUES_DCC_TARGETS_DN RODRIGUES_DCC_TARGETS_DN	-0.333	-0.333	0.697	-0.333	-0.866	-4.983	-0.333	1.111	1.111	0.697	0.534
BAUS_TFF2_TARGETS_UP BAUS_TFF2_TARGETS_UP	-1.367	-0.733	-1.367	0.231	0.231	2.092	0.453	0.231	0.453	1.577	-1.364
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	-0.663	1.292	2.696	0.762	-0.663	-0.247	-0.663	-0.663	0.362	-0.663	-0.661
RICKMAN_HEAD_AND_NECK_CANCER_F RICKMAN_HEAD_AND_NECK_CANCER_F	1.190	-0.622	0.397	-2.322	0.612	0.397	-1.501	-1.501	0.397	0.397	1.965
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	-0.508	-0.508	-0.786	2.411	-1.748	-0.786	0.459	-0.786	3.381	0.288	-0.505
ONDER_CDH1_TARGETS_1_UP ONDER_CDH1_TARGETS_1_UP	0.727	-0.735	-0.959	-1.231	-2.425	-1.559	0.565	0.727	1.605	1.880	0.734
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	0.722	-0.269	1.282	-0.634	-3.355	-2.804	0.574	0.722	-0.366	1.076	0.729
APPIERTO_RESPONSE_TO_FENRETINIDE_DN APPIERTO_RESPONSE_TO_FENRETINIDE_DN	-0.513	0.750	1.055	-0.301	-0.513	-2.114	0.750	1.818	0.498	-0.513	-2.108
YAGI_AML_WITH_T_9_11_TRANSLOCATION YAGI_AML_WITH_T_9_11_TRANSLOCATION	-1.766	0.518	1.553	0.518	-0.625	-4.290	-0.331	0.860	0.677	0.518	0.388
APPEL_IMATINIB_RESPONSE APPEL_IMATINIB_RESPONSE	-1.367	-0.385	-0.733	-0.733	-1.367	-0.733	0.453	1.130	0.453	0.754	2.677
ROSS_AML_WITH_AML1_ETO_FUSION ROSS_AML_WITH_AML1_ETO_FUSION	1.024	0.558	-0.820	-1.171	-0.559	-3.236	0.243	0.243	2.389	0.772	0.245
RAMALHO_STEMNESS_DN RAMALHO_STEMNESS_DN	0.288	-1.064	-0.488	-0.488	-2.144	-2.144	0.642	0.878	0.445	2.200	1.160
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	-0.313	0.793	-0.918	-1.680	-0.461	0.426	-0.659	-0.918	-0.918	1.024	4.421
DER_IFN_GAMMA_RESPONSE_UP DER_IFN_GAMMA_RESPONSE_UP	-0.668	-0.986	1.961	-0.438	-0.668	-2.945	-0.276	1.259	1.259	0.712	-0.435
HAN_JNK_SINGALING_DN HAN_JNK_SINGALING_DN	-0.283	0.555	-0.283	-0.525	-1.616	0.555	-1.616	-0.925	0.320	0.555	3.294
RODRIGUES_NTN1_AND_DCC_TARGETS RODRIGUES_NTN1_AND_DCC_TARGETS	-1.450	2.478	-0.219	-0.430	-0.796	-1.450	-0.430	-0.430	1.933	-0.219	0.683
RODWELL_AGING_KIDNEY_NO_BLOOD_DN RODWELL_AGING_KIDNEY_NO_BLOOD_DN	-0.292	0.708	0.708	0.708	-1.474	-2.759	1.081	1.800	-0.712	-1.832	0.714
KIM_WT1_TARGETS_12HR_UP KIM_WT1_TARGETS_12HR_UP	0.457	-1.556	-0.475	0.457	-1.556	-2.774	-0.261	0.345	0.738	1.534	2.345
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	-0.586	3.584	0.818	0.388	-0.885	-2.779	-0.586	-0.374	0.581	-0.374	0.240
LY_AGING_MIDDLE_DN LY_AGING_MIDDLE_DN	-0.663	3.556	1.292	-0.247	-0.663	-0.663	0.362	-0.247	-0.663	-0.247	-0.661
RICKMAN_HEAD_AND_NECK_CANCER_A RICKMAN_HEAD_AND_NECK_CANCER_A	2.608	-0.810	-1.097	-0.810	0.827	0.827	-0.280	-2.500	-1.097	0.827	0.833
VANASSE_BCL2_TARGETS_UP VANASSE_BCL2_TARGETS_UP	-0.341	0.836	-0.341	-0.671	-1.284	-1.284	0.264	-0.341	-0.341	0.264	4.296
HU_GENOTOXIC_DAMAGE_24HR HU_GENOTOXIC_DAMAGE_24HR	1.859	-1.492	-0.453	2.389	-0.453	-1.492	-0.234	-0.234	-0.828	0.646	-0.233
SMID_BREAST_CANCER_LUMINAL_B_UP SMID_BREAST_CANCER_LUMINAL_B_UP	0.468	0.601	-0.347	0.260	-2.277	0.601	-1.534	0.355	-2.277	1.810	1.823
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	-1.328	0.498	1.055	0.750	-0.513	-2.114	-0.301	2.270	0.750	-0.837	-0.833
PARK_TRETINOIN_RESPONSE PARK_TRETINOIN_RESPONSE	0.166	-0.497	-0.497	-0.497	-0.497	-0.497	-0.497	0.524	-0.497	3.495	1.055
HOLLEMAN_DAUNORUBICIN_B_ALL_DN HOLLEMAN_DAUNORUBICIN_B_ALL_DN	-0.497	-0.497	3.495	0.166	-0.497	-0.497	1.052	0.524	-0.497	-0.497	-0.496
APRELIKOVA_BRCA1_TARGETS APRELIKOVA_BRCA1_TARGETS	1.180	-1.990	1.180	0.351	-0.755	-1.990	-0.755	-0.256	1.180	0.351	0.574
LEIN_ASTROCYTE_MARKERS LEIN_ASTROCYTE_MARKERS	-0.354	1.040	-0.624	-1.057	-0.624	0.254	-1.782	0.453	-1.057	1.423	2.362
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	1.763	0.361	-1.439	-0.486	-1.819	-1.439	-1.439	0.490	1.245	1.245	1.029
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	1.083	0.476	-1.741	-1.741	-0.599	0.476	-0.336	-0.599	-0.599	1.083	1.935
NUTT_GBM_VS_AO_GLIOMA_UP NUTT_GBM_VS_AO_GLIOMA_UP	-1.158	-0.228	-1.158	-0.702	-1.907	-0.228	1.271	2.134	1.271	0.389	-0.409
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT	1.213	-0.462	-0.994	-0.994	-0.204	-0.462	-0.994	-0.204	-0.462	0.772	3.055
LEE_NEURAL_CREST_STEM_CELL_DN LEE_NEURAL_CREST_STEM_CELL_DN	1.595	0.870	-1.508	-0.661	-0.343	-0.885	-0.885	-0.885	-1.164	1.086	2.916
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	-0.311	2.414	-2.007	1.298	0.403	-2.485	0.403	0.536	0.693	-0.430	-1.266
DEMAGALHAES_AGING_UP DEMAGALHAES_AGING_UP	0.258	-0.348	-2.239	0.435	-0.921	-0.921	-0.921	0.258	0.944	0.664	3.063
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	1.998	-0.465	-0.623	-1.054	-0.340	-0.340	-2.576	-0.623	0.265	0.495	3.338
GENTILE_UV_RESPONSE_CLUSTER_D4 GENTILE_UV_RESPONSE_CLUSTER_D4	-0.578	0.664	0.664	2.543	-1.431	-2.239	0.664	0.435	0.435	-0.578	-0.916
LIU_SMARCA4_TARGETS LIU_SMARCA4_TARGETS	1.461	-0.810	-0.285	-0.810	-0.810	-0.492	-0.810	0.317	0.521	-1.294	4.004
WU_CELL_MIGRATION WU_CELL_MIGRATION	1.156	0.647	-0.674	-0.674	-0.525	-0.525	-2.307	-0.851	0.399	-0.402	4.368
WANG_CISPLATIN_RESPONSE_AND_XPC_UP WANG_CISPLATIN_RESPONSE_AND_XPC_UP	0.767	2.879	1.315	0.932	-2.359	-0.701	-0.318	-0.882	-1.637	-0.548	0.288
IVANOVSKA_MIR106B_TARGETS IVANOVSKA_MIR106B_TARGETS	-0.522	0.256	0.390	-0.351	-0.351	-2.658	0.256	4.510	0.557	-0.351	-1.047
BRACHAT_RESPONSE_TO_METHOTREXATE_UP BRACHAT_RESPONSE_TO_METHOTREXATE_UP	0.772	-0.462	-0.462	-0.994	-0.994	-0.994	-0.994	1.744	0.772	0.772	0.775
BURTON_ADIPOGENESIS_PEAK_AT_24HR BURTON_ADIPOGENESIS_PEAK_AT_24HR	-0.702	3.193	1.271	0.920	-0.702	-0.702	-0.702	-0.228	-0.411	-1.907	-0.226
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	-2.239	-0.578	-0.578	0.664	-0.921	-0.578	-0.921	2.076	0.435	0.664	1.660
SESTO_RESPONSE_TO_UV_C0 SESTO_RESPONSE_TO_UV_C0	-1.595	-0.909	1.163	1.715	-0.334	-1.214	-0.334	1.715	0.928	0.270	-2.061
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN	-1.051	-0.260	1.372	0.346	-3.183	-0.771	-0.385	2.334	-0.771	0.667	0.672
KRASNOSELSKAYA_ILF3_TARGETS_UP KRASNOSELSKAYA_ILF3_TARGETS_UP	-0.549	-0.549	-0.958	-0.958	-0.958	0.820	-0.958	0.527	-0.549	2.599	2.076
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_DN BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_DN	0.701	0.937	-0.888	-0.888	-0.888	-0.412	-2.400	-0.614	0.701	0.502	3.084
CHANDRAN_METASTASIS_TOP50_DN CHANDRAN_METASTASIS_TOP50_DN	-0.373	0.239	-0.373	0.430	-1.090	-1.824	-0.650	1.798	0.684	2.277	-1.086
WEBER_METHYLATED_ICP_IN_FIBROBLAST WEBER_METHYLATED_ICP_IN_FIBROBLAST	0.236	-0.870	-0.870	-0.870	1.436	0.236	0.930	-0.870	-0.870	1.436	0.529
ONDER_CDH1_TARGETS_3_DN ONDER_CDH1_TARGETS_3_DN	0.541	-0.691	-2.446	-0.434	0.784	2.676	-1.064	-0.691	-0.434	0.346	1.080
MADAN_DPPA4_TARGETS MADAN_DPPA4_TARGETS	1.367	0.330	-0.274	-1.642	1.367	-0.452	-0.452	-0.715	-2.488	0.519	1.374
MOHANKUMAR_HOXA1_TARGETS_DN MOHANKUMAR_HOXA1_TARGETS_DN	4.139	0.402	-1.100	-2.026	0.301	0.660	-0.533	-1.362	-0.689	0.522	0.667
BOWIE_RESPONSE_TO_TAMOXIFEN BOWIE_RESPONSE_TO_TAMOXIFEN	-0.746	-0.746	-0.298	-0.746	-0.746	-0.746	0.304	0.304	0.304	2.399	1.717
BURTON_ADIPOGENESIS_PEAK_AT_0HR BURTON_ADIPOGENESIS_PEAK_AT_0HR	1.593	-0.315	-0.786	-0.508	-1.748	-1.748	-0.786	-0.315	0.675	1.593	1.600
FARMER_BREAST_CANCER_CLUSTER_4 FARMER_BREAST_CANCER_CLUSTER_4	0.279	-0.787	-0.787	-0.787	-0.324	-0.324	-0.787	-0.324	0.279	1.613	3.025
DER_IFN_ALPHA_RESPONSE_UP DER_IFN_ALPHA_RESPONSE_UP	-1.064	-0.488	1.153	-1.064	-0.488	-3.070	0.445	0.878	1.153	1.153	0.291
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	-0.473	-0.313	1.366	2.034	-0.981	-1.364	0.831	1.082	0.435	-1.364	-1.861
RAMASWAMY_METASTASIS_UP RAMASWAMY_METASTASIS_UP	-0.566	1.825	1.132	1.825	-0.860	-1.855	0.405	0.405	0.250	-1.271	-1.266
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	-0.906	0.840	1.230	2.549	-1.143	-2.599	0.675	-0.543	0.840	-0.707	-0.701
AIGNER_ZEB1_TARGETS AIGNER_ZEB1_TARGETS	1.030	0.403	-0.796	-1.450	1.030	-0.796	-0.430	-1.450	-0.430	0.680	1.939
LY_AGING_PREMATURE_DN LY_AGING_PREMATURE_DN	-0.320	3.685	1.796	-0.640	-1.243	-0.320	-0.640	-0.320	-0.640	0.283	-0.638
LAU_APOPTOSIS_CDKN2A_UP LAU_APOPTOSIS_CDKN2A_UP	-0.600	1.232	-0.365	1.601	-1.466	-2.280	0.245	1.232	0.245	0.637	-0.945
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	0.501	-0.991	0.501	1.129	-0.574	-1.699	-0.574	0.501	-1.699	1.534	0.787
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	-1.117	-0.523	0.598	1.724	-0.523	-3.153	0.598	1.087	0.824	0.265	-0.771
NAGASHIMA_NRG1_SIGNALING_UP NAGASHIMA_NRG1_SIGNALING_UP	0.646	-0.893	0.646	-0.704	-0.310	-3.516	-0.893	1.381	-0.310	0.392	2.428
DELASERNA_MYOD_TARGETS_UP DELASERNA_MYOD_TARGETS_UP	-0.326	-0.326	1.644	-1.901	-0.711	-1.005	-0.711	0.419	-0.711	3.665	0.423
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	0.680	-0.219	-0.430	-1.450	-0.430	0.403	-1.450	-0.796	-0.430	2.478	1.454
BHATTACHARYA_EMBRYONIC_STEM_CELL BHATTACHARYA_EMBRYONIC_STEM_CELL	0.451	4.840	0.451	0.636	-0.458	-0.672	-0.301	-0.672	-1.836	-0.958	-0.454
LIN_MELANOMA_COPY_NUMBER_DN LIN_MELANOMA_COPY_NUMBER_DN	-0.991	1.129	0.501	1.129	-1.699	-1.699	0.783	0.285	0.285	0.783	-0.987
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53 AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	-0.651	0.405	-0.323	0.559	-1.567	-2.637	-0.889	0.405	1.191	2.789	0.409
BENPORATH_NOS_TARGETS BENPORATH_NOS_TARGETS	-0.270	0.564	2.495	1.690	-0.621	-3.710	-0.621	0.440	-0.363	-0.791	-0.266
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	-1.669	0.301	3.074	1.639	0.402	-2.440	0.522	-0.405	-0.301	-0.405	-0.869
REICHERT_MITOSIS_LIN9_TARGETS REICHERT_MITOSIS_LIN9_TARGETS	-0.260	2.675	0.347	1.503	-0.260	-1.119	-0.550	-0.260	0.347	-1.119	-1.116
SENGUPTA_EBNA1_ANTICORRELATED SENGUPTA_EBNA1_ANTICORRELATED	-0.301	-1.424	-0.707	-0.409	-2.144	-1.143	-0.543	1.230	1.230	1.964	1.467
HU_ANGIOGENESIS_DN HU_ANGIOGENESIS_DN	-0.250	3.503	0.359	1.332	-0.250	-0.860	-0.250	-0.250	-1.533	-0.860	-0.857
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4 PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	0.280	-0.465	-0.889	-3.409	-0.651	-0.465	-0.323	0.741	0.405	1.458	2.431
VARELA_ZMPSTE24_TARGETS_DN VARELA_ZMPSTE24_TARGETS_DN	1.477	-0.336	0.269	-1.024	-1.741	-0.599	-0.599	-1.024	0.476	0.749	2.440
FAELT_B_CLL_WITH_VH3_21_DN FAELT_B_CLL_WITH_VH3_21_DN	-1.259	0.814	-0.271	2.929	-0.271	-2.031	0.334	0.814	-0.782	0.334	-0.779
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	0.374	-0.752	-0.752	-0.328	-2.224	-1.490	0.374	0.374	0.630	4.164	0.498
SCIBETTA_KDM5B_TARGETS_DN SCIBETTA_KDM5B_TARGETS_DN	0.367	2.753	1.949	0.538	-1.675	-1.675	-0.842	-0.577	0.367	-0.383	-0.573
LANDIS_ERBB2_BREAST_TUMORS_65_UP LANDIS_ERBB2_BREAST_TUMORS_65_UP	-0.911	0.217	-0.911	1.932	-0.406	-0.911	-0.406	0.490	0.873	-0.911	1.361
ZHENG_GLIOBLASTOMA_PLASTICITY_DN ZHENG_GLIOBLASTOMA_PLASTICITY_DN	-1.035	0.564	-1.035	-1.035	-0.668	-0.247	-0.668	0.814	-1.035	2.747	1.852
LUCAS_HNF4A_TARGETS_UP LUCAS_HNF4A_TARGETS_UP	-0.247	0.564	1.844	-0.416	-1.571	-1.571	0.814	-1.571	1.456	0.564	-0.664
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP	1.846	-0.301	-0.566	-1.252	2.140	0.710	-0.751	-0.751	-2.455	1.097	-0.414
ROESSLER_LIVER_CANCER_METASTASIS_UP ROESSLER_LIVER_CANCER_METASTASIS_UP	-0.301	2.892	-0.438	1.524	-2.568	-0.849	-0.849	-0.849	0.432	0.783	-0.298
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	-1.225	-0.256	0.848	0.351	-0.755	-1.990	-0.755	1.565	1.180	1.180	-0.752
SERVITJA_LIVER_HNF1A_TARGETS_UP SERVITJA_LIVER_HNF1A_TARGETS_UP	0.782	1.984	-0.687	-1.487	-2.336	-0.265	-0.687	-0.903	0.611	0.464	1.996
NADLER_OBESITY_UP NADLER_OBESITY_UP	-0.452	-1.093	-0.715	-2.488	-0.274	-0.715	-0.274	0.756	1.039	1.739	1.374
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	0.291	-0.443	-1.099	0.936	-0.613	-3.790	0.291	0.413	0.291	2.326	0.741
LANDIS_ERBB2_BREAST_TUMORS_324_DN LANDIS_ERBB2_BREAST_TUMORS_324_DN	-0.975	-1.234	-1.234	1.016	-0.759	-1.543	-0.759	0.827	1.016	1.979	1.467
TAVOR_CEBPA_TARGETS_UP TAVOR_CEBPA_TARGETS_UP	-0.316	-0.316	-0.535	-0.316	-1.362	-2.156	-0.865	0.720	1.364	1.761	1.022
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	0.217	2.594	0.873	0.873	-0.911	-0.911	0.217	-0.911	0.217	-0.911	-0.404
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	-0.786	-0.786	-0.786	-0.315	-0.315	-0.786	-1.748	0.459	1.593	3.381	0.462
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	0.416	1.232	-2.280	0.637	0.245	-2.280	1.232	-0.600	0.245	0.416	0.247
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP	0.763	-0.921	-0.921	-0.526	-1.899	-1.511	-0.526	1.666	0.954	2.252	0.456
HUI_MAPK14_TARGETS_UP HUI_MAPK14_TARGETS_UP	1.521	-0.828	-0.351	-0.351	-0.828	-0.351	-0.828	-0.828	0.256	1.521	1.525
BROWNE_HCMV_INFECTION_24HR_DN BROWNE_HCMV_INFECTION_24HR_DN	0.469	-0.652	-1.731	0.348	-0.490	-2.145	-0.851	0.348	0.469	2.224	2.237
TOMLINS_PROSTATE_CANCER_UP TOMLINS_PROSTATE_CANCER_UP	-1.658	0.302	-0.300	2.599	-0.300	-1.658	0.302	1.176	-0.549	0.527	-0.546
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	-1.144	0.798	0.798	0.396	-1.144	-3.194	0.578	1.350	0.396	0.578	-0.537
BILANGES_SERUM_SENSITIVE_VIA_TSC2 BILANGES_SERUM_SENSITIVE_VIA_TSC2	-0.341	1.241	2.266	-0.341	0.264	-0.671	-1.284	1.241	-0.341	-0.671	-1.281
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	0.324	0.864	0.651	1.692	-0.418	-3.859	-0.418	0.324	0.472	0.324	-1.170
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN	-0.893	-0.266	-1.575	-0.266	-0.893	-0.893	0.339	2.222	1.278	1.278	-0.498
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP	-0.241	-1.077	-0.241	-1.077	-0.241	-1.077	-0.241	0.684	-0.520	1.088	2.799
LEIN_MEDULLA_MARKERS LEIN_MEDULLA_MARKERS	0.806	-1.901	-1.392	0.419	-2.584	0.278	0.806	0.595	0.806	-0.326	1.339
DE_YY1_TARGETS_DN DE_YY1_TARGETS_DN	-0.418	2.395	1.385	0.472	-0.606	-2.845	-0.418	1.109	-0.606	-0.418	-0.849
DITTMER_PTHLH_TARGETS_DN DITTMER_PTHLH_TARGETS_DN	-1.999	0.342	0.997	0.737	-0.264	-1.393	-0.264	0.997	1.636	-1.999	-0.261
BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN	-1.432	-0.443	-1.099	0.561	-0.613	-2.982	0.561	0.936	0.936	1.417	0.943
FARMER_BREAST_CANCER_CLUSTER_5 FARMER_BREAST_CANCER_CLUSTER_5	-0.787	0.609	0.279	0.279	0.279	-0.787	1.057	2.269	-0.787	-0.787	-0.785
MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT	-0.671	0.264	-0.341	-0.671	1.241	-1.284	-1.284	-0.341	0.509	0.264	2.887
LIU_SOX4_TARGETS_UP LIU_SOX4_TARGETS_UP	-1.252	-0.418	0.414	-0.301	-0.977	-2.455	-0.301	2.454	1.575	1.097	-0.561
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	0.262	1.595	0.870	1.886	-3.087	-1.508	0.262	-0.483	0.376	0.262	-0.656
MORI_PLASMA_CELL_UP MORI_PLASMA_CELL_UP	-0.332	-0.893	-0.332	-0.556	-0.893	-1.397	0.691	3.135	1.706	0.272	-0.888
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	-1.241	1.560	1.330	1.118	-0.608	-1.534	0.754	1.330	-1.534	-0.992	-0.602
FU_INTERACT_WITH_ALKBH8 FU_INTERACT_WITH_ALKBH8	-0.538	0.967	0.476	3.261	-0.538	-0.538	-0.538	-0.176	-0.176	-0.538	-0.537
HEDENFALK_BREAST_CANCER_BRACX_DN HEDENFALK_BREAST_CANCER_BRACX_DN	-0.828	-0.351	0.991	2.148	-0.351	-0.828	-0.828	0.991	0.566	-0.828	-0.350
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	1.245	-1.439	-0.867	-1.439	-0.867	0.361	-0.352	-0.486	-0.352	1.021	3.458
TERAMOTO_OPN_TARGETS_CLUSTER_7 TERAMOTO_OPN_TARGETS_CLUSTER_7	2.399	-0.746	-0.746	0.655	0.655	0.304	-0.746	-0.746	-0.746	0.655	-0.297
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	-0.704	-0.704	-0.272	-0.704	-0.704	-0.704	0.332	1.206	-0.272	1.821	1.210
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	0.559	0.559	0.842	2.356	-1.373	-3.236	0.559	-0.458	0.442	0.341	-1.120
MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP	0.640	-0.414	0.211	0.211	-0.414	-0.414	-0.414	-0.414	-0.414	-0.414	4.075
NIKOLSKY_BREAST_CANCER_17P11_AMPLICON NIKOLSKY_BREAST_CANCER_17P11_AMPLICON	0.640	0.211	-0.414	-0.414	-0.414	-0.414	0.211	-0.414	4.069	-0.414	-0.413
MENSE_HYPOXIA_UP MENSE_HYPOXIA_UP	0.524	-0.521	0.249	1.740	-0.360	-3.107	-0.521	1.740	-0.521	0.921	-1.000
OHGUCHI_LIVER_HNF4A_TARGETS_DN OHGUCHI_LIVER_HNF4A_TARGETS_DN	0.445	-1.926	-1.281	-1.027	0.445	1.507	-0.269	-1.578	0.574	0.574	2.310
LEIN_CEREBELLUM_MARKERS LEIN_CEREBELLUM_MARKERS	-1.005	0.595	0.595	-1.392	-0.489	0.419	-1.901	-0.489	-0.489	1.331	2.781
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	-1.381	-0.373	-0.250	0.896	-2.399	-1.381	1.136	1.702	0.507	0.896	-0.533
RIEGE_DELTANP63_DIRECT_TARGETS_UP RIEGE_DELTANP63_DIRECT_TARGETS_UP	-0.735	2.495	0.727	0.912	-0.959	-2.425	-1.231	0.310	-0.292	1.120	-0.403
LIM_MAMMARY_LUMINAL_MATURE_UP LIM_MAMMARY_LUMINAL_MATURE_UP	0.511	-2.132	0.511	-0.950	-0.357	-1.261	-0.703	0.367	0.367	0.682	3.444
UEDA_PERIFERAL_CLOCK UEDA_PERIFERAL_CLOCK	-1.623	-0.845	1.456	0.547	-1.063	-1.976	-0.845	1.236	1.236	0.690	0.697
LY_AGING_MIDDLE_UP LY_AGING_MIDDLE_UP	-0.199	-0.580	-0.580	-0.580	0.434	0.892	-0.580	-0.580	-0.580	2.211	0.894
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN	-0.373	-0.373	-0.373	-0.373	-0.373	-0.373	0.240	4.432	0.240	-0.373	0.240
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP	1.870	-0.343	-1.112	-1.112	-0.725	-0.725	-1.633	0.263	0.452	0.859	2.689
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP	0.166	-0.497	-0.497	-0.497	3.495	0.524	0.524	-0.497	-0.497	-0.497	0.167
